Processing 00000000.tx.1: Depletion of Mitochondrial DNA Causes Impaired Glucose Utilization and Insulin Resistance in L6 GLUT4myc Myocytes* Seung Y. 

Phrase: "Depletion of Mitochondrial DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   770   C0333668:Depletion [Functional Concept]

Phrase: "Causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Impaired Glucose Utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "Insulin Resistance in L6 GLUT4myc Myocytes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "* Seung Y."
Processing 00000000.tx.2: Park, Guem H. 

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "Guem H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.3: Choi, Hyo I. 

Phrase: "Choi,"

Phrase: "Hyo I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.4: Choi, Jiwon Ryu, Chan Y. 

Phrase: "Choi,"

Phrase: "Jiwon Ryu,"

Phrase: "Chan Y."
Processing 00000000.tx.5: Jung, and Wan Lee From the Department of Biochemistry, College of Medicine, Dongguk University, Kyungju 780-714, Korea, and the Biophysics Laboratory, Veterans Affairs Medical Center, Department of Physiology and Biophysics, School of Medicine, State University of New York, Buffalo, New York 14215 Received for publication, August 16, 2004 , and in revised form, November 18, 2004.  

Phrase: "Jung,"

Phrase: "and"

Phrase: "Wan Lee From the Department of Biochemistry,"

Phrase: "College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0557806:College [Manufactured Object]

Phrase: "Dongguk University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Kyungju 780-714,"

Phrase: "Korea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: "and"

Phrase: "the Biophysics Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1549054:Veterans Affairs [Organization]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0042610:Veterans [Population Group]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   779 E C3245459:veteran [Intellectual Product]

Phrase: "Department of Physiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biophysics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005553:Biophysics [Biomedical Occupation or Discipline]

Phrase: "School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036375:School [Manufactured Object,Organization]

Phrase: "State University of New York,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0027976:New York [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205314:New [Temporal Concept]
   804   C1301808:State [Geographic Area]
   804   C1442792:State [Functional Concept]
   804   C3148680:State [Geographic Area]

Phrase: "Buffalo,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006352:Buffalo [Mammal]
  1000   C0324533:BUFFALO [Mammal]
  1000   C1739095:Buffalo [Mammal]

Phrase: "New York 14215"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "August 16,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "November 18,"

Phrase: "2004."
Processing 00000000.tx.6: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Mitochondrial dysfunction contributes to a number of human diseases, such as hyperlipidemia, obesity, and diabetes. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "contributes to a number of human diseases,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0086418:Human [Human]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1880177:Contribute [Activity]

Phrase: "such as hyperlipidemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020473:Hyperlipidaemia [Disease or Syndrome]

Phrase: "obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.7: The mutation and reduction of mitochondrial DNA (mtDNA) have been suggested as factors in the pathogenesis of diabetes. 

Phrase: "The mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "reduction of mitochondrial DNA (mtDNA)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "suggested as factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1521761:Factor [Functional Concept]
   756   C1705535:Suggest [Idea or Concept]
   756   C2827422:Factor [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.8: To elucidate the association of cellular mtDNA content and insulin resistance, we produced L6 GLUT4myc myocytes depleted of mtDNA by long term treatment with ethidium bromide. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the association of cellular mtDNA content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we"

Phrase: "produced"

Phrase: "L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "depleted of mtDNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0333668:Depleted [Functional Concept]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "by long term treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023977:long-term treatment [Health Care Activity]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0443252:Long-term [Temporal Concept]

Phrase: "with ethidium bromide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.9: L6 GLUT4myc cells cultured with 0.2 g/ml ethidium bromide (termed depleted cells) revealed a marked decrease in cellular mtDNA and ATP content, concomitant with a lack of mRNAs encoded by mtDNA. 

Phrase: "L6 GLUT4myc cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "cultured with 0.2 g/ml ethidium bromide"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   770   C1300565:g/mL [Quantitative Concept]
   767 E C1637390:mL/g [Quantitative Concept]
   744   C0006222:Bromide [Inorganic Chemical]
   744   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   744   C0439267:g% [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   711   C0010453:Culture [Idea or Concept]
   711   C0220814:culture [Functional Concept]
   711   C0430400:Culture [Laboratory Procedure]
   711   C2242979:Culture [Laboratory Procedure]

Phrase: "(termed depleted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a marked decrease in cellular mtDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "ATP content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "concomitant with a lack of mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0521115:Concomitant [Temporal Concept]

Phrase: "encoded by mtDNA."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C0679058:encoded [Mental Process]
   770   C2700640:Encoded [Activity]
Processing 00000000.tx.10: Interestingly, the mtDNA-depleted cells showed a drastic decrease in basal and insulin-stimulated glucose uptake, indicating that L6 GLUT4myc cells develop impaired glucose utilization and insulin resistance. 

Phrase: "Interestingly,"

Phrase: "the mtDNA-depleted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a drastic decrease in basal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "insulin-stimulated glucose uptake,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "indicating"

Phrase: "that L6 GLUT4myc cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "develop"

Phrase: "impaired glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.11: The repletion of mtDNA normalized basal and insulin-stimulated glucose uptake. 

Phrase: "The repletion of mtDNA"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.12: The mRNA level and expression of insulin receptor substrate (IRS)-1 associated with insulin signaling were decreased by 76 and 90% in the depleted cells, respectively. 

Phrase: "The mRNA level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "expression of insulin receptor substrate (IRS)-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597360:receptor expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "associated with insulin signaling"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0037083:Signaling [Cell Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3537152:signaling [Biologic Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "were"

Phrase: "decreased by 76"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "90% in the depleted cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0333668:Depleted [Functional Concept]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.13: The plasma membrane (PM) GLUT4 in the basal state was decreased, and the insulin-stimulated GLUT4 translocation to the PM was drastically reduced by mtDNA depletion. 

Phrase: "The plasma membrane (PM) GLUT4 in the basal state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1420175:GLUT4 [Gene or Genome]
   744   C2982484:GLUT4 [Gene or Genome]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "the insulin-stimulated GLUT4 translocation to the PM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0040715:Translocation [Cell or Molecular Dysfunction]
   742   C2987521:Translocation [Activity]

Phrase: "was"

Phrase: "drastically"

Phrase: "reduced by mtDNA depletion."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0333668:Depletion [Functional Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0521451:Mitochondrial [Functional Concept]
Processing 00000000.tx.14: Moreover, insulin-stimulated phosphorylation of IRS-1 and Akt2/protein kinase B were drastically reduced in the depleted cells. 

Phrase: "Moreover,"

Phrase: "insulin-stimulated phosphorylation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Akt2/protein kinase B"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0164786:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0166559:AKT2 Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           AKT2 Kinase
   923   C0285558:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "drastically"

Phrase: "reduced in the depleted cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0333668:Depleted [Functional Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.15: Those changes returned to control levels after mtDNA repletion. 

Phrase: "Those changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "returned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332156:Return [Qualitative Concept]

Phrase: "to control levels after mtDNA repletion."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0243148:control [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.16: Taken together, our data suggest that PM GLUT4 content and insulin signal pathway intermediates are modulated by the alteration of cellular mtDNA content, and the reductions in the expression of IRS-1 and insulin-stimulated phosphorylation of IRS-1 and Akt2/protein kinase B are associated with insulin resistance in the mtDNA-depleted L6 GLUT4myc myocytes.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PM GLUT4 content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "insulin signal pathway intermediates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0205103:Intermediate [Spatial Concept]
   779   C1550465:intermediate [Idea or Concept]
   779   C2827755:INTERMEDIATE [Laboratory or Test Result]
   708   C2984427:Insulin Pathway [Functional Concept]

Phrase: "are"

Phrase: "modulated by the alteration of cellular mtDNA content,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C1819717:mitochondrial DNA [Cell Component]
   762   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   762   C0596611:DNA Alteration [Genetic Function]
   762   C2267112:DNA Alteration [Cell Function]
   742   C0007634:Cellular [Cell]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0178539:Cellular [Functional Concept]
   742   C0423896:Content [Mental Process]
   742   C0443264:Modulated [Spatial Concept]
   742   C0456205:Content [Conceptual Entity]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "the reductions in the expression of IRS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0301630:reductions [Natural Phenomenon or Process]
   739   C0441610:reductions [Therapeutic or Preventive Procedure]
   706 E C0392756:Reduction [Qualitative Concept]

Phrase: "and"

Phrase: "insulin-stimulated phosphorylation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Akt2/protein kinase B"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0164786:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0166559:AKT2 Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           AKT2 Kinase
   923   C0285558:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in the mtDNA-depleted L6 GLUT4myc myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596981:Myocytes [Cell]
Processing 00000000.tx.17: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The pathophysiology of non-insulin-dependent diabetes mellitus (NIDDM)1 results from impaired peripheral tissue sensitivity to insulin and reduction of insulin secretion. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The pathophysiology of non-insulin-dependent diabetes mellitus (NIDDM)1 results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031847:pathophysiology [Functional Concept]
   739   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "from impaired peripheral tissue sensitivity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   861   C0234235:Tissue sensitivity [Sign or Symptom]
   812   C0036667:Sensitivity [Quantitative Concept]
   812   C0312418:Sensitivity [Mental Process]
   812   C0427965:Sensitivity [Finding]
   812   C1511883:Sensitivity [Quantitative Concept]
   812   C1522640:Sensitivity [Qualitative Concept]
   812   C2346484:SENSITIVITY [Phenomenon or Process]
   812   C2349185:Sensitivity [Qualitative Concept]
   741 E C0332324:Sensitive [Functional Concept]
   741 E C1550474:sensitive [Idea or Concept]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "reduction of insulin secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.18: Glucose uptake in mammalian cells is mediated by a family of intrinsic membrane proteins known as facilitative glucose transporters, GLUTs (1, 2). 

Phrase: "Glucose uptake in mammalian cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1159527:glucose uptake [Cell Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "is"

Phrase: "mediated by a family of intrinsic membrane proteins"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   783   C0021699:Intrinsic Membrane Protein [Amino Acid, Peptide, or Protein]
   770   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   750   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0015576:Family [Family Group]
   744   C0025255:Membrane [Tissue]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0205102:Intrinsic [Spatial Concept]
   744   C0439674:Intrinsic [Functional Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1704727:Family [Conceptual Entity]
   744   C1706182:Membrane [Manufactured Object]

Phrase: "known as facilitative glucose transporters,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205309:Known [Qualitative Concept]
   760   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "GLUTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1335837:GLUT [Gene or Genome]
   966   C1705603:GLUT [Gene or Genome]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: GLUT4, the insulin-responsive glucose transporter, is selectively expressed in muscle and adipose cells (3). 

Phrase: "GLUT4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "the insulin-responsive glucose transporter,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0166441:Insulin-Responsive Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE [Gene or Genome]
   861   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "selectively"

Phrase: "expressed in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026845:Muscle [Tissue]
   718 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "adipose cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0206131:adipose cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: GLUT4 in these cells constantly recycles between the plasma membrane and intracellular storage pools (4, 5). 

Phrase: "GLUT4 in these cells constantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1420175:GLUT4 [Gene or Genome]
   760   C2982484:GLUT4 [Gene or Genome]

Phrase: "recycles between the plasma membrane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "intracellular storage pools"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0337051:pools [Geographic Area]
   793 E C1509144:pool [Clinical Attribute]
   793 E C2349200:Pool [Functional Concept]
   734   C1659466:intracellular storage [Cell Function]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: About 90% of GLUT4 is sequestered intracellularly in the absence of insulin or other stimuli such as exercise (6, 7). 

Phrase: "About 90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "of GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "is"

Phrase: "sequestered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:Sequestered [Functional Concept]

Phrase: "intracellularly in the absence of insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "other stimuli such as exercise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0234402:Stimuli [Phenomenon or Process]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.22: Insulin stimulates glucose uptake in these cells primarily by inducing net translocation of GLUT4 from the intracellular storage sites to the plasma membrane (8, 9). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "glucose uptake in these cells primarily"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1159527:glucose uptake [Cell Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "by inducing net translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]

Phrase: "of GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "from the intracellular storage sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
   734   C1659466:intracellular storage [Cell Function]

Phrase: "to the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.23: The reduction in cellular GLUT4 expression, GLUT4 translocation, and/or impaired insulin signaling would result in insulin resistance and hyperglycemia, the primary characteristics and hallmarks of NIDDM (10). 

Phrase: "The reduction in cellular GLUT4 expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "GLUT4 translocation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]

Phrase: "and/or"

Phrase: "impaired insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "would"

Phrase: "result in insulin resistance"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1274040:Result [Functional Concept]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1546471:Result [Idea or Concept]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2825142:Result [Finding]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "the primary characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "hallmarks of NIDDM"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   897   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   897   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   853   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   778   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1518422:Non [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.24: It is generally accepted that NIDDM is a polygenic disorder composed of subtypes whereby genetic susceptibility is strongly associated with environmental factors (11). 

Phrase: "It"

Phrase: "is"

Phrase: "generally"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "that NIDDM"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a polygenic disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorder [Disease or Syndrome]

Phrase: "composed of subtypes whereby genetic susceptibility"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0314657:Genetic Susceptibility [Organism Attribute]
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C0314603:Genetic [Functional Concept]
   753   C0449560:subtypes [Classification]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "is"

Phrase: "strongly"

Phrase: "associated with environmental factors"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1516998:Environmental Factors [Functional Concept]
   816 E C0686732:Environmental Factor [Qualitative Concept]
   770   C0014406:Environmental [Spatial Concept]
   737 E C0750490:Associate [Idea or Concept]
   737   C1521761:Factor [Functional Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.25: Maternally inherited mitochondrial DNA (mtDNA), which encodes 22 tRNAs, 13 subunits of the electron transport system, and its own 16 and 26 S ribosomal RNAs, has been considered one of the genetic factors for the development of diabetes (12, 13). 

Phrase: "Maternally"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "mitochondrial DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "(mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "22 tRNAs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1537998:trnA [Gene or Genome]

Phrase: "13 subunits of the electron transport system,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "its own 16"

Phrase: "and"

Phrase: "26 S ribosomal RNAs,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0035701:Ribosomal RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1622954:ribosomal RNA [Cell Component]
   812   C0035553:Ribosomal [Cell Component]
   812   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]
   741 E C2984240:Ribosome [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "considered one of the genetic factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "for the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.26: Although mtDNA within the cells is heteroplasmic, it has been reported that 0.51.5% of diabetics over the age of 40 exhibit mtDNA abnormalities such as duplications (14), point mutations (15), and large scale deletions (16). 

Phrase: "Although"

Phrase: "mtDNA within the cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]

Phrase: "is"

Phrase: "heteroplasmic,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that 0.51.5% of diabetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0444499:0/5 [Quantitative Concept]
   753   C0241863:diabetics [Finding]

Phrase: "over the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "mtDNA abnormalities such as duplications"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0000768:Abnormalities [Congenital Abnormality]
   753   C0000769:abnormalities [Functional Concept]
   719 E C1704258:Abnormality [Finding]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "large scale deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1880274:Deletions [Activity]
   793 E C1442161:Deletion [Cell or Molecular Dysfunction]
   793 E C1511760:Deletion [Genetic Function]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.27: Furthermore, the cellular oxidative capacity, which is mostly dependent on mitochondrial function, is directly correlated with insulin sensitivity in skeletal muscles (1719), and reduced mitochondrial oxidation and phosphorylation determined by NMR are associated with insulin resistance in skeletal muscle of elderly people (20), raising the possibility that impaired mitochondrial function results in insulin resistance. 

Phrase: "Furthermore,"

Phrase: "the cellular oxidative capacity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "mostly dependent on mitochondrial function,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "correlated with insulin sensitivity"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0920563:Insulin Sensitivity [Pathologic Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1707520:Correlated [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in skeletal muscles"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0242692:Skeletal muscles, NOS [Tissue]
   966 E C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscles [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   861   C1995013:Muscles [Body Part, Organ, or Organ Component]
   777 E C0442025:Muscular [Spatial Concept]

Phrase: "(1719"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "reduced mitochondrial oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "determined by NMR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0024485:NMR [Diagnostic Procedure]
   790   C0028580:NMR [Natural Phenomenon or Process]

Phrase: "are"

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "of elderly people"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027361:People [Population Group]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that impaired mitochondrial function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "results in insulin resistance."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1274040:Result [Functional Concept]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1546471:Result [Idea or Concept]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2825142:Result [Finding]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.28: Moreover, the quantitative analysis of mtDNA revealed a decrease in mtDNA content in diabetic animals and humans (2123). 

Phrase: "Moreover,"

Phrase: "the quantitative analysis of mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0200898:DNA analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0392762:Quantitative [Quantitative Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a decrease in mtDNA content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "in diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "(2123"

Phrase: ")."
Processing 00000000.tx.29: Similarly cellular content of mtDNA in the pancreatic islets of Goto-Kakizaki rat was markedly decreased without major deletion or restriction fragment polymorphism in mtDNA (21). 

Phrase: "Similarly cellular content of mtDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "in the pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "of Goto-Kakizaki rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "decreased without major deletion"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0205164:Major [Qualitative Concept]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "or"

Phrase: "restriction fragment polymorphism in mtDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032529:Polymorphism [Genetic Function]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.30: Southern blot analyses from type 1 and type 2 diabetic patients also revealed that the cellular mtDNA copy number in skeletal muscles was 50% of normal (22). 

Phrase: "Southern blot analyses from type 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   799   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   753   C1710133:Southern [Spatial Concept]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "type 2 diabetic patients also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the cellular mtDNA copy number in skeletal muscles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1707513:Copy Number [Quantitative Concept]
   762   C0006556:Copy DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1948062:Copy [Manufactured Object]

Phrase: "was"

Phrase: "50% of normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.31: Lee et al. 

Phrase: "Lee et al."
Processing 00000000.tx.32: (23) also reported that the quantitative decrease of mtDNA in lymphocytes preceded the type 2 diabetic development, suggesting that the decreased content of mtDNA might be a causal factor in type 2 diabetes. 

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the quantitative decrease of mtDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "in lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]

Phrase: "preceded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:preceded [Temporal Concept]

Phrase: "the type 2 diabetic development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0243107:development [Physiologic Function]
   812   C0678723:Development [Organism Function]
   812   C1527148:Development [Functional Concept]
   741 E C0458003:Developmental [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the decreased content of mtDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "might"

Phrase: "be"

Phrase: "a causal factor in type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0960756:factor A [Organic Chemical]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.33: However, there is as yet no convincing evidence that the reduction of cellular mtDNA content in peripheral tissues such as muscle cells is responsible for the disturbances in the glucose uptake and insulin resistance. 

Phrase: "However,"

Phrase: "there"

Phrase: "is as yet"

Phrase: "no convincing evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the reduction of cellular mtDNA content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in peripheral tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "such as muscle cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0596981:Muscle Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0026845:Muscle [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "is"

Phrase: "responsible for the disturbances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in the glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.34: It has been reported that long term treatment of cells with low doses (0.12 g/ml) of ethidium bromide (EtBr), an inhibitor of DNA/RNA synthesis, specifically suppresses the replication and transcription of extrachromosomal genetic components such as mtDNA without affecting nuclear DNA replication and transcription (2426). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that long term treatment of cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0023977:long-term treatment [Health Care Activity]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with low doses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0445550:Low dose [Quantitative Concept]
   983   C1708745:Low-Dose [Research Activity]
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "(0.12 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "ml) of ethidium bromide (EtBr),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "an inhibitor of DNA/RNA synthesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "specifically"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the replication"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0598312:Replication [Genetic Function]
  1000   C1883725:replication [Qualitative Concept]
   928 E C0205173:Replicate [Functional Concept]
   928 E C0205341:Replicate [Functional Concept]

Phrase: "and"

Phrase: "transcription of extrachromosomal genetic components"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0040649:Transcription, Genetic [Genetic Function]
           Transcription

Phrase: "such as mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "without affecting nuclear DNA replication"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0598312:DNA Replication [Genetic Function]
           Replication
   861   C2984261:DNA replication [Functional Concept]
   812   C1883725:replication [Qualitative Concept]
   741 E C0205173:Replicate [Functional Concept]
   741 E C0205341:Replicate [Functional Concept]

Phrase: "and"

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "(2426"

Phrase: ")."
Processing 00000000.tx.35: Therefore, mtDNA-depleted cells have been important tools in the investigation of the cellular components regulated by mtDNA (27). 

Phrase: "Therefore,"

Phrase: "mtDNA-depleted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "important tools in the investigation of the cellular components"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0336791:Tool [Manufactured Object]
   708   C2827396:Tool [Manufactured Object]

Phrase: "regulated by mtDNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.36: Several lines of evidence obtained from mtDNA-depleted cells have revealed that mitochondrial stress resulting from the reduction of mtDNA causes substantial activation and inactivation of nuclear DNA-encoded gene expression (2831). 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "obtained from mtDNA-depleted cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   790   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1819717:mitochondrial DNA [Cell Component]
   753   C0007634:Cells [Cell]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0333668:Depleted [Functional Concept]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1706701:Obtain [Activity]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that mitochondrial stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "resulting from the reduction of mtDNA"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C1819717:mitochondrial DNA [Cell Component]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C0678226:resulting [Functional Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "substantial activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "inactivation of nuclear DNA-encoded gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0598496:Gene Inactivation [Genetic Function]
   748   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "(2831"

Phrase: ")."
Processing 00000000.tx.37: However, it is not clear whether the mtDNA depletion is a contributing factor in the expression of molecules responsible for the insulin signaling and GLUT4 translocation. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "the mtDNA depletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   827   C0333668:Depletion [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "is"

Phrase: "a contributing factor in the expression of molecules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   767   C0960756:factor A [Organic Chemical]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "responsible for the insulin signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "GLUT4 translocation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]
Processing 00000000.tx.38: In the present study, we report that the depletion of mtDNA in L6 GLUT4myc myocytes is directly correlated with drastic reduction in basal glucose utilization and resistance to insulin stimulation as shown by glucose uptake and GLUT4 translocation. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the depletion of mtDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   926   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   760   C0333668:Depletion [Functional Concept]

Phrase: "in L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "correlated with drastic reduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "in basal glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "resistance to insulin stimulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0021655:Insulin Resistance [Pathologic Function]
   819   C2700570:INSULIN RESISTANCE [Gene or Genome]
   797   C0332325:Resistant to [Functional Concept]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]

Phrase: "as"

Phrase: "shown by glucose uptake"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1159527:glucose uptake [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "GLUT4 translocation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]
Processing 00000000.tx.39: The expression level of IRS-1 was also reduced in the depleted cells with drastic reduction in the insulin-stimulated GLUT4 translocation to the PM, and the insulin-stimulated phosphorylations of IRS-1 and protein kinase B (Akt2/PKB) were decreased in the depleted cells. 

Phrase: "The expression level of IRS-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C3244092:expression level [Idea or Concept]
   767   C0202098:Insulin level [Laboratory Procedure]
   767   C0428405:insulin level [Laboratory or Test Result]
   767   C0456947:Level 1 [Intellectual Product]
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "also"

Phrase: "reduced in the depleted cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0333668:Depleted [Functional Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with drastic reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in the insulin-stimulated GLUT4 translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040715:Translocation [Cell or Molecular Dysfunction]
   812   C2987521:Translocation [Activity]

Phrase: "to the PM,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "the insulin-stimulated phosphorylations of IRS-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0031715:Phosphorylations [Molecular Function]
   708 E C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "protein kinase B"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0164786:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0285558:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Akt2/PKB"

Phrase: ")"

Phrase: "were"

Phrase: "decreased in the depleted cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0333668:Depleted [Functional Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.40: These findings strongly suggest that the GLUT4 contents in the PM and insulin signal pathway intermediates are modulated by the alteration of cellular mtDNA content and that the reductions in the expression of IRS-1 and the insulin-stimulated phosphorylation of IRS-1 and Akt2/PKB are associated with insulin resistance in the mtDNA-depleted L6 GLUT4myc myocytes.  

Phrase: "These findings strongly"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the GLUT4 contents in the PM"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0456205:Contents [Conceptual Entity]
   748   C1552853:contents [Idea or Concept]
   714 E C0423896:Content [Mental Process]

Phrase: "and"

Phrase: "insulin signal pathway intermediates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0205103:Intermediate [Spatial Concept]
   779   C1550465:intermediate [Idea or Concept]
   779   C2827755:INTERMEDIATE [Laboratory or Test Result]
   708   C2984427:Insulin Pathway [Functional Concept]

Phrase: "are"

Phrase: "modulated by the alteration of cellular mtDNA content"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C1819717:mitochondrial DNA [Cell Component]
   762   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   762   C0596611:DNA Alteration [Genetic Function]
   762   C2267112:DNA Alteration [Cell Function]
   742   C0007634:Cellular [Cell]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0178539:Cellular [Functional Concept]
   742   C0423896:Content [Mental Process]
   742   C0443264:Modulated [Spatial Concept]
   742   C0456205:Content [Conceptual Entity]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the reductions in the expression of IRS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0301630:reductions [Natural Phenomenon or Process]
   739   C0441610:reductions [Therapeutic or Preventive Procedure]
   706 E C0392756:Reduction [Qualitative Concept]

Phrase: "and"

Phrase: "the insulin-stimulated phosphorylation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Akt2/PKB"

Phrase: "are"

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in the mtDNA-depleted L6 GLUT4myc myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596981:Myocytes [Cell]
Processing 00000000.tx.41: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  MaterialsAnti-GLUT4 antibody (clone 1F8) and anti-GLUT1 antibody were purchased from Biogenesis Ltd. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "MaterialsAnti-GLUT4 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(clone 1F8"

Phrase: ")"

Phrase: "and"

Phrase: "anti-GLUT1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Biogenesis Ltd."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005495:Biogenesis [Natural Phenomenon or Process]
   770   C0220781:Biogenesis [Biologic Function]
   770   C0869011:purchased [Activity]
   770   C1136140:LTD [Organ or Tissue Function]
Processing 00000000.tx.42: (Sandown, NH). 

Phrase: "(Sandown,"

Phrase: "NH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.43: IRAP antibody was kindly provided by Dr. 

Phrase: "IRAP antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.44: Kozma (Metabolex Inc., Hayward, CA). 

Phrase: "Kozma"

Phrase: "(Metabolex Inc.,"

Phrase: "Hayward,"

Phrase: "CA)."
Processing 00000000.tx.45: Antibody against IRS-1, IRS-2, phosphatidylinositol 3-kinase (PI3K), Akt2/PKB, and 3-phosphoinositide-dependent protein kinase-1 (PDK-1) were purchased from Upstate Biotechnology, Inc. 

Phrase: "Antibody against IRS-1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   820   C0443876:Insulin receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0021644:Insulin antibody [Immunologic Factor]
   783   C0034805:antibody receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   716   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "IRS-2,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0381451:Insulin Receptor Substrate-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334141:INSULIN RECEPTOR SUBSTRATE 2 [Gene or Genome]
  1000   C1334191:Insulin Receptor Substrate 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "phosphatidylinositol 3-kinase (PI3K),"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Akt2/PKB,"

Phrase: "and"

Phrase: "3-phosphoinositide-dependent protein kinase-1 (PDK-1)"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C0541150:3-Phosphoinositide Dependent Protein Kinase-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335204:3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 [Gene or Genome]
   947   C0538677:3-phosphoinositide-dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0089793:Phosphoinositide Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031621:phosphoinositide [Biologically Active Substance,Lipid]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439086:<3 [Quantitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C2827736:3+ [Quantitative Concept]
   799   C2981702:3+ [Classification]
   799   C3244310:dependent [Functional Concept]

Phrase: "were"

Phrase: "purchased from Upstate Biotechnology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   770   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.46: (Lake Placid, NY). 

Phrase: "(Lake Placid, NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.47: Antibody against phospho-IRS-1 was a generous gift from Dr. 

Phrase: "Antibody against phospho-IRS-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0443876:Insulin receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0021644:Insulin antibody [Immunologic Factor]
   774   C0034805:antibody receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "a generous gift from Dr."
Processing 00000000.tx.48: Pann-Ghill Suh (Postech, Pohang, Korea). 

Phrase: "Pann-Ghill Suh"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1416171:SUH [Gene or Genome]
   827   C1422188:SUH [Gene or Genome]

Phrase: "(Postech,"

Phrase: "Pohang,"

Phrase: "Korea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: ")."
Processing 00000000.tx.49: Anti-phospho-Akt2 antibody was from Cell Signaling (Beverly, MA). 

Phrase: "Anti-phospho-Akt2 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was from Cell Signaling"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0037083:Cell Signaling [Cell Function]
           Signaling
   770   C0007634:Cell [Cell]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1269647:Cell [Cell]
   770   C1421478:WAS [Gene or Genome]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C3537152:signaling [Biologic Function]

Phrase: "(Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.50: Horseradish peroxidase-labeled protein A and anti-mouse IgG were obtained from Zymed Laboratories Inc. 

Phrase: "Horseradish peroxidase-labeled protein A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "anti-mouse IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "obtained from Zymed Laboratories Inc."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C1301820:Obtained [Functional Concept]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C1706701:Obtain [Activity]
   726 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.51: (San Francisco, CA). 

Phrase: "(San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.52: Anti--actin antibody, insulin (porcine crystalline), and O-phenylenediamine dihydrochloride were purchased from Sigma. 

Phrase: "Anti--actin antibody,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   755 E C0439681:Actinic [Qualitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(porcine crystalline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444626:Crystalline [Chemical Viewed Structurally]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "O-phenylenediamine dihydrochloride"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0043796:o-phenylenediamine [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.53: Monoclonal antibody 9E10 for c-myc was purchased from Santa Cruz Biotechnology, Inc. 

Phrase: "Monoclonal antibody 9E10 for c-myc"

Phrase: "was"

Phrase: "purchased from Santa Cruz Biotechnology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.54: (Santa Cruz, CA). 

Phrase: "(Santa Cruz,"

Phrase: "CA)."
Processing 00000000.tx.55: Oligonucleotide primers were from Bionics (Seoul, Korea). 

Phrase: "Oligonucleotide primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "were from Bionics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0005549:Bionics [Occupation or Discipline]

Phrase: "(Seoul,"

Phrase: "Korea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: ")."
Processing 00000000.tx.56: All other chemicals were standard commercial products of reagent grade quality except for individually stated reagents. 

Phrase: "All"

Phrase: "other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "standard commercial products of reagent grade quality"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C1547887:Commercial Product [Manufactured Object]
   757   C0681522:product quality [Qualitative Concept]
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "except for individually stated reagents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.57: Cell CultureThe parent cell line used in this study was L6 GLUT4myc, an L6 cell line (provided by Dr. Amira Klip (the Hospital for Sick Children, Toronto, Canada)) expressing GLUT4-myc, constructed by inserting a human c-myc epitope (14 amino acids) into the first ectodomain of rat GLUT4 (32). 

Phrase: "Cell CultureThe parent cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0007600:Cell Line [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "L6 GLUT4myc,"

Phrase: "an L6 cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "provided by Dr. Amira Klip"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1426024:KLIP [Gene or Genome]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1999230:Provided [Activity]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: "("

Phrase: "the Hospital for Sick Children,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0020017:Children's hospital [Health Care Related Organization]
   760   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   760   C1510665:Hospital [Qualitative Concept]

Phrase: "Toronto,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: ")"

Phrase: "expressing GLUT4-myc,"

Phrase: "constructed by inserting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0441587:Insert [Health Care Activity]
   756   C1743766:Insert [Medical Device]
   756   C1883719:Insert [Functional Concept]
   756   C2827421:Construct [Classification]

Phrase: "a human c-myc epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003316:Epitope [Immunologic Factor]

Phrase: "(14 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "into the first ectodomain"

Phrase: "of rat GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420175:GLUT4 [Gene or Genome]
   861   C2982484:GLUT4 [Gene or Genome]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.58: Cells were maintained in -minimal essential medium supplemented with 10% fetal bovine serum in a humidified atmosphere of air and 5% CO2 at 37 C. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "in -minimal essential medium"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   812   C0009458:Medium [Intellectual Product]
   812   C0205224:Essential [Qualitative Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C0547040:Minimal [Qualitative Concept]
   812   C1524031:MINIMAL [Qualitative Concept]
   812   C1705217:Medium [Substance]
   812   C2945599:Minimal [Qualitative Concept]
   812   C3244283:medium [Intellectual Product]
   741 E C1552614:minimum [Idea or Concept]
   741 E C2826545:MINIMUM [Quantitative Concept]

Phrase: "supplemented with 10% fetal bovine serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "in a humidified atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004178:Atmosphere [Natural Phenomenon or Process]
   861   C0678214:atmosphere [Quantitative Concept]

Phrase: "of air"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001861:Air [Substance]
  1000   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   916 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "5% CO2 at 37 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.59: The L6 GLUT4myc cell line with partially depleted mtDNA was isolated by treating L6 GLUT4myc myocytes with EtBr (0.2 g/ml) and uridine (50 g/ml) for 3 weeks in -minimal essential medium supplemented with 10% fetal bovine serum. 

Phrase: "The L6 GLUT4myc cell line with partially"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0007600:Cell Line [Cell]
   774   C0007634:THE CELL [Cell]
           Cell
   748   C0205132:Line [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "was"

Phrase: "isolated by treating L6 GLUT4myc myocytes"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0205409:Isolated [Functional Concept]
   753   C0332293:treating [Therapeutic or Preventive Procedure]
   753   C0596981:Myocytes [Cell]
   753   C1522326:Treating [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "with EtBr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "(0.2 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "uridine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041984:Uridine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(50 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) for 3 weeks in -minimal essential medium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439526:/mL [Quantitative Concept]

Phrase: "supplemented with 10% fetal bovine serum."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.60: The control parental L6 GLUT4myc myocytes were maintained for the same time period in normal culture condition. 

Phrase: "The control parental L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596981:Myocytes [Cell]

Phrase: "were"

Phrase: "maintained for the same time period"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0439582:Time period [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0439531:/period [Temporal Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1948053:Period [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
   719 E C0024501:Maintain [Activity]

Phrase: "in normal culture condition."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0231162:Normal condition [Finding]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   755 E C0009647:Conditioned [Mental Process]
   755 E C1701901:Conditional [Qualitative Concept]
   755 E C1963686:Conditional [Functional Concept]
   727 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.61: Since the depletion of mtDNA in myoblast treated with EtBr severely impairs the formation of myotube (33), which makes L6 GLUT4myc myocyte differentiation less quantitative and less reproducible, and since L6 GLUT4myc myocytes without differentiation possess GLUT4 recycling compartments, insulin-sensitive glucose uptake and the insulin signaling intermediates similar to primary muscle cells (3439), we used L6 GLUT4myc myocytes to study how insulin stimulates glucose utilization. 

Phrase: "Since"

Phrase: "the depletion of mtDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   926   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   760   C0333668:Depletion [Functional Concept]

Phrase: "in myoblast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596995:Myoblast [Cell]

Phrase: "treated with EtBr severely"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0006222:Bromide [Inorganic Chemical]
   760   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   760   C0205082:Severely [Qualitative Concept]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "impairs"

Phrase: "the formation of myotube"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "L6 GLUT4myc myocyte differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0007589:Differentiation [Cell Function]
   812   C1511938:Differentiation [Clinical Attribute]
   812   C2945687:Differentiation [Functional Concept]
   741 E C0205615:Differentiated [Qualitative Concept]

Phrase: "less quantitative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392762:Quantitative [Quantitative Concept]

Phrase: "and"

Phrase: "less reproducible,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C1514863:Reproducibility [Qualitative Concept]

Phrase: "and"

Phrase: "since L6 GLUT4myc myocytes without differentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596981:Myocytes [Cell]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "GLUT4 recycling compartments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1185625:Compartments [Body Space or Junction]
   827   C1382196:Compartments [Natural Phenomenon or Process]
   793 E C2986730:Compartment [Spatial Concept]

Phrase: "insulin-sensitive glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "the insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "similar to primary muscle cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "(3439"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "L6 GLUT4myc myocytes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596981:Myocytes [Cell]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "how insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "glucose utilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]
Processing 00000000.tx.62: Myocytes were deprived of serum for 5 h prior to all experimental manipulations. 

Phrase: "Myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596981:Myocytes [Cell]

Phrase: "were"

Phrase: "deprived of serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]

Phrase: "for 5 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "prior to all experimental manipulations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185111:MANIPULATIONS [Therapeutic or Preventive Procedure]
   861   C0947647:Manipulations NOS [Therapeutic or Preventive Procedure]
Processing 00000000.tx.63: Staining of Functional MitochondriaL6 GLUT4myc myocytes were incubated with the mitochondria-specific cationic fluorescent dye, Mitotracker Green (Molecular Probes, Inc., Eugene, OR), for 15 min at 37 C and washed three times with prewarmed phosphate-buffered saline (PBS). 

Phrase: "Staining of Functional MitochondriaL6 GLUT4myc myocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "were"

Phrase: "incubated with the mitochondria-specific cationic fluorescent dye,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]
   744   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   744   C0026237:Mitochondria [Cell Component]
   744   C0205369:Specific [Qualitative Concept]
   744   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1552740:specific [Intellectual Product]

Phrase: "Mitotracker Green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332583:Green [Qualitative Concept]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Inc.,"

Phrase: "Eugene,"

Phrase: "OR"

Phrase: ")"

Phrase: ","

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37 C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "washed three times with prewarmed phosphate-buffered saline (PBS)."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0040223:times [Temporal Concept]
   744   C1632851:Times [Quantitative Concept]
   711 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.64: The cell preparations were visualized and photographed in a fluorescence microscope (Zeiss). 

Phrase: "The cell preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0920433:cell preparation [Laboratory Procedure]
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "and"

Phrase: "photographed in a fluorescence microscope"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0181839:Microscope [Medical Device]
   760   C1706379:Microscope [Medical Device]
   726   C0441468:photograph [Manufactured Object]

Phrase: "(Zeiss"

Phrase: ")."
Processing 00000000.tx.65: The fluorescent intensity reflects the integrity of mitochondrial function (40). 

Phrase: "The fluorescent intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the integrity of mitochondrial function"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.66: Measurement of Cellular ATP LevelsThe cellular ATP was measured by using a somatic cell ATP assay kit (Sigma) as previously described (28). 

Phrase: "Measurement of Cellular ATP LevelsThe cellular ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0242485:Measurement [Functional Concept]

Phrase: "was"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a somatic cell ATP assay kit (Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1719918:Sigma [Intellectual Product]
   700   C1266250:Somatic cell assay [Laboratory Procedure]

Phrase: ")"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.67: Briefly, the harvested L6 GLUT4myc cells were lysed with "ATP-releasing reagent," and the lysates were assayed with injector-equipped luminometer detection (Lumat LB 9501, Berthold, Germany) for luciferase activity as described in the manufacturer's procedure. 

Phrase: "Briefly,"

Phrase: "the harvested L6 GLUT4myc cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed with ""ATP-releasing reagent,"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0024348:lysed [Pathologic Function]
   760   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   760   C1283071:Releasing [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0391871:Release [Functional Concept]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: """"

Phrase: "and"

Phrase: "the lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "assayed with injector-equipped luminometer detection"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0181342:Injector [Medical Device]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "(Lumat LB 9501,"

Phrase: "Berthold,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "for luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "described in the manufacturer's procedure."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0947322:Manufacturer [Intellectual Product]
   760   C1552738:described [Idea or Concept]
   760   C1705426:Manufacturer [Population Group]
   760   C1948041:Procedure [Therapeutic or Preventive Procedure]
   760   C2700391:Procedure [Activity]
   760   C3274430:PROCEDURE [Health Care Activity]
   760   C3538935:Procedure [Idea or Concept]
   760   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.68: Genomic DNA Extraction and PCRTotal cellular DNA was extracted according to the manufacturer's instructions by using DNeasy Tissue kit (Qiagen, Hilden, Germany). 

Phrase: "Genomic DNA Extraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]
   734   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PCRTotal cellular DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted according to the manufacturer's instructions"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1442085:Instructions [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   753   C3263700:Instructions [Clinical Attribute]
   753   C3541890:EXTRACTED [Finding]
   719 E C0039401:Instruction [Educational Activity]
   719 E C2828366:Extract [Substance]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DNeasy Tissue kit (Qiagen,"

Phrase: "Hilden,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.69: The amplification of mtDNA was performed in a PerkinElmer Life Sciences 2400 PCR thermocycler using the following conditions: 94 C for 2 min (initial denaturation), 94 C for 30 s, 60 C for 30 s, 72 C for 45 s (25 cycles), 72 C for 10 min (final extension). 

Phrase: "The amplification of mtDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683230:DNA amplification [Genetic Function]
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "performed in a PerkinElmer Life Sciences 2400 PCR thermocycler"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C0005526:Life Sciences [Occupation or Discipline]
   742   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0036397:Sciences [Occupation or Discipline]
   742   C0376558:Life [Idea or Concept]
   742   C0677874:pCR [Finding]
   742   C0884358:Performed [Functional Concept]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: ":"

Phrase: "94 C for 2 min (initial denaturation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "94 C for 30 s,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "60 C for 30 s,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "72 C for 45"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "s ("

Phrase: "25 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "72 C for 10 min (final extension"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.70: The primers used are shown in Table I. 

Phrase: "The primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "shown in Table I."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.71: View this table: [in this window] [in a new window]  TABLE I DNA sequence of primers and optimal conditions for RT-PCR  RNA PreparationTotal RNA was extracted using a standard Trizol RNA isolation protocol (Invitrogen). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I DNA sequence of primers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "optimal conditions for RT-PCR  RNA PreparationTotal RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0012634:condition [Disease or Syndrome]
   711   C0348080:Condition [Qualitative Concept]
   711   C1705253:Condition [Conceptual Entity]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a standard Trizol RNA isolation protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0442711:Protocol [Intellectual Product]
   804   C1507394:Protocol [Intellectual Product]
   804   C1522729:Protocol [Intellectual Product]
   804   C2348563:Protocol [Intellectual Product]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.72: Briefly, 1 ml of Trizol reagent was mixed with cell pellet (5 x 105 cells) by repeated pipetting. 

Phrase: "Briefly,"

Phrase: "1 ml of Trizol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "mixed with cell pellet"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0007634:Cell [Cell]
   770   C0205430:Mixed [Functional Concept]
   770   C0441436:Pellet [Manufactured Object]
   770   C0993610:Pellet [Biomedical or Dental Material]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C1998480:Pellet [Quantitative Concept]
   770   C3160715:Mixed [Finding]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "(5 x 105 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "by repeated pipetting."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0182301:Pipette [Medical Device]
   827   C1706407:Pipette [Medical Device]
Processing 00000000.tx.73: DNA and protein were excluded by chloroform phase separation. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "excluded by chloroform phase separation."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0036679:Separation [Pathologic Function]
   760   C0205390:Phase [Temporal Concept]
   760   C0237868:Separation [Social Behavior]
   760   C1554077:Excluded [Idea or Concept]
   760   C1881713:SEPARATION [Phenomenon or Process]
   760   C2828389:Excluded [Activity]
   726 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.74: RNA in the aqueous phase was precipitated with isopropyl alcohol and then resuspended in diethyl pyrocarbonate-treated water. 

Phrase: "RNA in the aqueous phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "precipitated with isopropyl alcohol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0022237:Isopropyl Alcohol [Organic Chemical,Pharmacologic Substance]
   770   C0001962:ALCOHOL [Organic Chemical]
   770   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   770   C2945717:isopropyl [Chemical Viewed Structurally]
   737   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resuspended in diethyl pyrocarbonate-treated water."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0012186:Diethyl Pyrocarbonate [Organic Chemical,Pharmacologic Substance]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0212509:pyrocarbonate [Organic Chemical]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C0599638:WATER [Substance]
   753   C1522326:Treated [Functional Concept]
   753   C1550678:Water [Inorganic Chemical]
   719 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.75: The quantity and quality of the isolated RNA were determined by absorbance at 260 and 280 nm. 

Phrase: "The quantity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1265611:Quantity [Quantitative Concept]
  1000   C1554108:Quantity [Intellectual Product]
  1000   C1561573:Quantity [Intellectual Product]

Phrase: "and"

Phrase: "quality of the isolated RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332306:Quality [Qualitative Concept]

Phrase: "were"

Phrase: "determined by absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1268822:Absorbance [Clinical Attribute]
   790   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 260"

Phrase: "and"

Phrase: "280 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.76: RT-PCR AnalysisRT-PCR analysis was performed as described previously (41). 

Phrase: "RT-PCR AnalysisRT-PCR analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0200931:PCR analysis [Laboratory Procedure]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.77: The PCR conditions were established in our laboratory to allow comparisons between the expression of transcripts, which relate insulin signaling and glucose uptake. 

Phrase: "The PCR conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "established in our laboratory to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C0443211:Established [Qualitative Concept]
   760   C1272684:Established [Qualitative Concept]
   760   C3244292:laboratory [Functional Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "comparisons between the expression of transcripts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707455:Comparison [Activity]

Phrase: "which"

Phrase: "relate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0163712:Relate [Organic Chemical]

Phrase: "insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.78: Under these conditions, the efficiency of the RT-PCR for each gene did not plateau, and the number of cycles used in these experiments was kept to a minimum. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the efficiency of the RT-PCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013682:Efficiency [Quantitative Concept]

Phrase: "for each gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "did"

Phrase: "not plateau,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2964353:Plateau [Quantitative Concept]

Phrase: "and"

Phrase: "the number of cycles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "used in these experiments"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "kept to a minimum."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1524031:Minimum [Qualitative Concept]
   770   C1552614:minimum [Idea or Concept]
   770   C2826545:MINIMUM [Quantitative Concept]
   737   C0333118:Keep [Functional Concept]
Processing 00000000.tx.79: The relative expression levels of mRNA were determined by using 1.0 g of total RNA as template and the optimal cycles of PCR with the optimal thermal conditions (Table I). 

Phrase: "The relative expression levels of mRNA"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C1515670:mRNA Expression [Genetic Function]
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1.0 g of total RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   753   C0439267:g% [Quantitative Concept]

Phrase: "as template"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0728990:TEMPLATE [Medical Device]
  1000   C1514575:Template [Conceptual Entity]
  1000   C1705542:Template [Idea or Concept]

Phrase: "and"

Phrase: "the optimal cycles of PCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1511572:Cycle [Temporal Concept]

Phrase: "with the optimal thermal conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.80: As a control, we analyzed the transcription levels of -actin and glyceraldehyde-3-phosphate dehydrogenase using specific rat primers, the same amount of total RNA, and 25 PCR cycles. 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the transcription levels of -actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "glyceraldehyde-3-phosphate dehydrogenase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific rat primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the same amount of total RNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "25 PCR cycles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.81: These were optimal conditions for the analysis of mRNA expression, and the analysis was limited to the products generated in the exponential phase of the amplification. 

Phrase: "These"

Phrase: "were"

Phrase: "optimal conditions for the analysis of mRNA expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0012634:condition [Disease or Syndrome]
   711   C0348080:Condition [Qualitative Concept]
   711   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "the analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "limited to the products"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0439801:Limited [Functional Concept]
   770   C1514468:Products [Entity]
   770   C3542948:Limited [Intellectual Product]
   737 E C1549649:Limit [Idea or Concept]
   737 E C1704444:Product [Quantitative Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "generated in the exponential phase of the amplification."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205390:Phase [Temporal Concept]
   744   C1517480:Amplification [Molecular Biology Research Technique]
   744   C1521871:Amplification [Phenomenon or Process]
   744   C1552645:exponential [Qualitative Concept]
   744   C1705759:Amplification [Cell or Molecular Dysfunction]
   744   C3146294:Generated [Activity]
Processing 00000000.tx.82: After RT-PCR, the content of each independent reaction tube was subjected to electrophoresis on 23% agarose gels containing EtBr. 

Phrase: "After RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "the content of each independent reaction tube"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "subjected to electrophoresis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "on 23% agarose gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "EtBr."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.83: Images from electrophoresed gels were captured by a camera in a computer-assisted imaging system (AlphaImager 1220; Alphainotech Co., San Leandro, CA). 

Phrase: "Images from electrophoresed gels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1704254:Image [Intellectual Product]
   737   C1704922:Image [Entity]
   737   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured by a camera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0179533:Camera [Medical Device]
   770   C1654607:Camera [Eukaryote]
   770   C1706254:CAMERA [Medical Device]

Phrase: "in a computer-assisted imaging system"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   902   C0009612:Computer System [Intellectual Product,Manufactured Object]
   861   C2697665:Imaging System [Manufactured Object]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
   708   C0596446:computer imaging [Machine Activity]

Phrase: "(AlphaImager 1220"

Phrase: "; Alphainotech Co.,"

Phrase: "San Leandro,"

Phrase: "CA)."
Processing 00000000.tx.84: Quantitative Gene Expression AnalysisIn order to confirm gene expression levels, quantitative real time RT-PCR (qRT-PCR) was carried out in Rotor Gene 2000 (Corbett Research, Mortlake, Australia) using SYBR-Green PCR Master Mix according to the manufacturer's instructions (Qiagen, Valencia, CA). 

Phrase: "Quantitative Gene Expression AnalysisIn"

Phrase: "order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "gene expression levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0017262:Gene Expression [Genetic Function]

Phrase: "quantitative real time RT-PCR (qRT-PCR)"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   911   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   888   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in Rotor Gene 2000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017337:Gene [Gene or Genome]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]

Phrase: "(Corbett Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "Mortlake,"

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SYBR-Green PCR Master Mix according to the manufacturer's instructions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205430:Mix [Functional Concept]
   739   C1421951:MIX [Gene or Genome]
   739   C1720722:Mix [Qualitative Concept]

Phrase: "(Qiagen,"

Phrase: "Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA)."
Processing 00000000.tx.85: All of the gene-specific primer sets used for qRT-PCR are listed in Table I. 

Phrase: "All of the gene-specific primer sets"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C1366517:SET gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0036849:Set [Mental Process]
   748   C0205369:Specific [Qualitative Concept]
   748   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0444868:All [Quantitative Concept]
   748   C1442518:Set [Functional Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1705195:Set [Conceptual Entity]
   748   C3539085:All [Idea or Concept]

Phrase: "used for qRT-PCR"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   804   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   804   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   778   C1550177:Real Time [Idea or Concept]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0040223:Time [Temporal Concept]
   748   C0237400:Real [Qualitative Concept]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0677874:pCR [Finding]
   748   C1273517:used [Finding]
   748   C3272377:REAL [Intellectual Product]
   748   C3541383:Time [Temporal Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "listed in Table I."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.86: After amplification, the authenticity of the PCR products was verified by melting curve analysis and agarose gel electrophoresis. 

Phrase: "After amplification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "the authenticity of the PCR products"

Phrase: "was"

Phrase: "verified by melting curve analysis"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205134:Curve [Spatial Concept]
   760   C0599882:Melting [Natural Phenomenon or Process]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1711411:Verified [Functional Concept]
   726 E C0050572:MELT [Therapeutic or Preventive Procedure]
   726 E C1540179:MELT [Gene or Genome]

Phrase: "and"

Phrase: "agarose gel electrophoresis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   901   C1706746:Agarose Gel [Research Device]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0036681:Agarose [Carbohydrate]
   827   C1382104:Gel [Substance]
Processing 00000000.tx.87: Images from electrophoresed gels were captured by a camera in a computer-assisted imaging system (AlphaImager 1220). 

Phrase: "Images from electrophoresed gels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1704254:Image [Intellectual Product]
   737   C1704922:Image [Entity]
   737   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured by a camera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0179533:Camera [Medical Device]
   770   C1654607:Camera [Eukaryote]
   770   C1706254:CAMERA [Medical Device]

Phrase: "in a computer-assisted imaging system"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   902   C0009612:Computer System [Intellectual Product,Manufactured Object]
   861   C2697665:Imaging System [Manufactured Object]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
   708   C0596446:computer imaging [Machine Activity]

Phrase: "(AlphaImager 1220"

Phrase: ")."
Processing 00000000.tx.88: The qRT-PCR results were analyzed using Rotor-Gene analysis software version 6.0 (Corbett Research). 

Phrase: "The qRT-PCR results"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   878   C1709795:Quantitative Result [Finding]
   766   C1274040:Result [Functional Concept]
   766   C1546471:Result [Idea or Concept]
   766   C2825142:Result [Finding]
   719   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   700   C1709846:Real-Time PCR [Molecular Biology Research Technique]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Rotor-Gene analysis software version 6.0"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0002778:Analysis [Laboratory Procedure]
   795   C0017337:Gene [Gene or Genome]
   795   C0037585:Software [Intellectual Product,Manufactured Object]
   795   C0333052:Version [Functional Concept]
   795   C0936012:Analysis [Research Activity]
   795   C1524024:analysis [Functional Concept]
   795   C2607870:Version [Spatial Concept]

Phrase: "(Corbett Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: ")."
Processing 00000000.tx.89: The comparative cycle threshold (CT) method was used to analyze the data by generating relative values of the amount of target cDNA. 

Phrase: "The comparative cycle threshold (CT) method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the data by generating relative values of the amount of target cDNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C1511726:Data [Idea or Concept]
   736   C3245479:data [Medical Device]
   734   C1704610:Data Value [Intellectual Product]
Processing 00000000.tx.90: Relative quantitation for any given gene, expressed as percentage variation over control, was calculated after determination of the difference between CT of the given gene A and that of the calibrator gene B (-actin) in the depleted or reverted myocytes (CT1 = CT1A  CTB) and control myocytes (CT0 = CT0A  CTB) using the 2CT(10) formula. 

Phrase: "Relative quantitation for any given gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantitation [Quantitative Concept]

Phrase: "expressed as percentage variation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205419:Variation [Qualitative Concept]
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "over control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "calculated after determination of the difference"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0444686:Calculated [Functional Concept]
   753   C1148554:determination [Laboratory Procedure]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "of the given gene A"

Phrase: "and"

Phrase: "that of the calibrator gene B (-actin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0017337:Gene [Gene or Genome]
   748   C0179515:CALIBRATOR [Manufactured Object]
   748   C1706424:Calibrator [Medical Device]

Phrase: ")"

Phrase: "in the depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "or"

Phrase: "reverted myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596981:Myocytes [Cell]

Phrase: "(CT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332801:CT-1 [Gene or Genome]
  1000   C1707158:CT-1 [Gene or Genome]

Phrase: "= CT1A  CTB"

Phrase: ")"

Phrase: "and"

Phrase: "control myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596981:Myocytes [Cell]

Phrase: "(CT0"

Phrase: "= CT0A  CTB"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 2CT"

Phrase: "(10"

Phrase: ")"

Phrase: "formula."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0489829:Formula [Intellectual Product]
  1000   C1705501:Formula [Intellectual Product]
Processing 00000000.tx.91: CT values are means of triplicate measurements. 

Phrase: "CT values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0042295:Values [Qualitative Concept]
   812   C0449864:Threshold [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means of triplicate measurements."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.92: Experiments were repeated 35 times. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "35 times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.93: Determination of 2-Deoxyglucose (2DG) and 3-O-Methylglucose (3OMG) UptakeCells were starved of serum for 4 h and washed twice with Hepes-buffered saline solution (140 mM NaCl, 20 mM Na-Hepes, 2.5 mM MgSO4, 1 mM CaCl2, and 5 mM KCl, pH 7.4). 

Phrase: "Determination of 2-Deoxyglucose (2DG)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "3-O-Methylglucose (3OMG) UptakeCells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0047666:3-O-Methylglucose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "were"

Phrase: "starved of serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   756   C2348531:Starve [Activity]

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with Hepes-buffered saline solution"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0036082:Saline Solution [Substance]
           Saline
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]

Phrase: "(140 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "20 mM Na-Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "2.5 mM MgSO4,"

Phrase: "1 mM CaCl2,"

Phrase: "and"

Phrase: "5 mM KCl,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.94: 2DG and 3OMG uptakes were measured as described previously (42). 

Phrase: "2DG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]
           Deoxyglucose

Phrase: "and"

Phrase: "3OMG uptakes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0243144:uptakes [Physiologic Function]
   779 E C0347980:% uptake [Quantitative Concept]
   756   C0047666:3-O-Methylglucose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.95: Briefly, cells were incubated for 20 min in the presence or absence of insulin (100 nM) and then 2DG uptake (10 M [14C]2DG, 1 Ci/ml, PerkinElmer Life Sciences) was measured for 3 min. 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 20 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(100 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "then 2DG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "(10"

Phrase: "M ["

Phrase: "14C"

Phrase: "]2DG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]
           Deoxyglucose

Phrase: "1 Ci/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2348025:Ci/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "measured for 3 min."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0444706:Measured [Qualitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.96: Nonspecific uptake was determined in the presence of 10 M cytochalasin B and was subtracted from all values. 

Phrase: "Nonspecific uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "determined in the presence of 10 M cytochalasin B"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0010737:Cytochalasin B [Biologically Active Substance,Pharmacologic Substance]
   742   C0010739:Cytochalasin [Biologically Active Substance,Pharmacologic Substance]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "was"

Phrase: "subtracted from all values."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]
   737   C1719767:Subtract [Intellectual Product]
   737   C2348589:Subtract [Phenomenon or Process]
Processing 00000000.tx.97: 3OMG uptake was measured in a similar fashion with the following differences: 50 M [14C]3OMG (4 Ci/ml; PerkinElmer Life Sciences) was added to Hepes-buffered saline solution, and uptake was allowed to occur for 15 s, a period over which 3OMG uptake is known to be linear. 

Phrase: "3OMG uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]
   756   C0047666:3-O-Methylglucose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "measured in a similar fashion"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0444706:Measured [Qualitative Concept]
   760   C2348205:Similar [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "with the following differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: ":"

Phrase: "50"

Phrase: "M ["

Phrase: "14C"

Phrase: "]3OMG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047666:3-O-Methylglucose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(4 Ci/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2348025:Ci/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "added to Hepes-buffered saline solution,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0036082:Saline Solution [Substance]
           Saline
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1524062:Added [Functional Concept]
   719 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur for 15 s,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "a period over which 3OMG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439531:/period [Temporal Concept]
   744   C1948053:Period [Temporal Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "linear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205132:Linear [Spatial Concept]
Processing 00000000.tx.98: Subcellular FractionationMembrane preparations were performed as described previously for wild type L6 cells (34). 

Phrase: "Subcellular FractionationMembrane preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously for wild type L6 cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C1883559:Wild Type [Organism Attribute]
   783   C0449475:cells type [Intellectual Product]
   783   C0450116:L6 type [Intellectual Product]
   767 E C0007634:Cell Type [Cell]
           Cells
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.99: Equal amounts of membrane proteins were analyzed by SDS-PAGE and electrotransferred onto nitrocellulose paper filters. 

Phrase: "Equal amounts of membrane proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "electrotransferred onto nitrocellulose paper filters."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C0180859:paper filter [Medical Device]
   760   C0030351:Paper [Manufactured Object]
   760   C0180860:Filters [Manufactured Object]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C1547566:Paper [Idea or Concept]
   726 E C0581406:Filter [Medical Device]
   726 E C1522664:Filter [Intellectual Product]
   726 E C1704449:Filter [Conceptual Entity]
   726 E C1704684:Filter [Medical Device]
   726 E C1875155:FILTER [Medical Device]
Processing 00000000.tx.100: Gel Electrophoresis and ImmunoblottingMembranes solubilized in Laemmli solution were subjected to SDS-PAGE on 8 or 10% resolving gels as described (43). 

Phrase: "Gel Electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596607:Gel Electrophoresis [Laboratory Procedure]
   861   C0013855:Electrophoresis [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "ImmunoblottingMembranes"

Phrase: "solubilized in Laemmli solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "on 8"

Phrase: "or"

Phrase: "10% resolving gels as described"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0017243:Gels [Biomedical or Dental Material]
   726 E C1382104:Gel [Substance]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.101: Separated proteins were electrophoretically transferred to nitrocellulose membrane (Bio-Rad), blocked with 5% nonfat milk in Tris-buffered saline, and incubated with primary antibodies in TTBS (Tris-buffered saline plus 0.05% Tween 20) containing 1% nonfat milk. 

Phrase: "Separated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "electrophoretically"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Bio-Rad"

Phrase: ")"

Phrase: ","

Phrase: "blocked with 5% nonfat milk"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0026131:Milk [Body Substance]
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C0349374:Milk [Food]
   760   C0444318:Milk [Substance]
   760   C2825079:Milk [Food]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
   704 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   704 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "in Tris-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "and"

Phrase: "incubated with primary antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in TTBS"

Phrase: "(Tris-buffered saline plus 0.05% Tween 20"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   795   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   793   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   793   C0036082:Saline [Substance]
   793   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   793   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   793   C0332287:Plus [Qualitative Concept]
   793   C0814229:TRI [Intellectual Product]
   784 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   737 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% nonfat milk."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0026131:Milk [Body Substance]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]
Processing 00000000.tx.102: After overnight incubation, membranes were washed with TTBS and incubated with horseradish peroxidase-labeled protein A (for the detection of polyclonal antibodies) or horseradish peroxidase-labeled anti-mouse IgG (for the detection of monoclonal antibodies). 

Phrase: "After overnight incubation,"

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "washed with TTBS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "incubated with horseradish peroxidase-labeled protein A"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   778   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0330510:Horseradish [Food]
   748   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   748   C1110641:Horseradish [Plant]
   748   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1708632:Labeled [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "("

Phrase: "for the detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "horseradish peroxidase-labeled anti-mouse IgG (for the detection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   784   C0063351:IGG-horseradish peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "of monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.103: Proteins were visualized using an enhanced chemiluminescent substrate kit (PerkinElmer Life Sciences). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enhanced chemiluminescent substrate kit (PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   818   C0005526:Life Sciences [Occupation or Discipline]
   795   C0036397:Sciences [Occupation or Discipline]
   795   C0376558:Life [Idea or Concept]
   712 E C0595998:lives [Finding]

Phrase: ")."
Processing 00000000.tx.104: Immunoblot intensities were quantitated by densitometry using an analytical scanning system (AlphaImager 1220). 

Phrase: "Immunoblot intensities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:intensities [Qualitative Concept]

Phrase: "were"

Phrase: "quantitated by densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011321:Densitometry [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an analytical scanning system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(AlphaImager 1220"

Phrase: ")."
Processing 00000000.tx.105: Measurement of GLUT4myc TranslocationThe movement of myc-tagged GLUT4 to the cell surface was measured by an antibody-coupled colorimetric assay (34) with slight modifications. 

Phrase: "Measurement of GLUT4myc TranslocationThe movement of myc-tagged GLUT4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0427044:Movement measurement [Finding]
   742   C0242485:Measurement [Functional Concept]

Phrase: "to the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "was"

Phrase: "measured by an antibody-coupled colorimetric assay"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1948027:Coupled [Functional Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0010222:couple [Family Group]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "(34"

Phrase: ")"

Phrase: "with slight modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.106: Quiescent L6 GLUT4myc cells treated as indicated were washed once with PBS and fixed with 3.7% paraformaldehyde in PBS for 3 min at room temperature, and the fixative was immediately neutralized by incubation with 1% glycine in PBS at 4 C for 10 min. 

Phrase: "Quiescent L6 GLUT4myc cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with PBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C1441704:Prewarmed [Laboratory Procedure]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   753   C1720092:Once [Intellectual Product]
   753   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "fixed with 3.7% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C2827483:Fixed [Body Substance]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0036082:Saline [Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 3 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "the fixative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016184:Fixative [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "neutralized by incubation"

Phrase: "with 1% glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0522461:Glycine [Plant]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0036082:Saline [Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "at 4 C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.107: The cells were blocked with 3% bovine serum albumin in PBS at room temperature for 1 h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "blocked with 3% bovine serum albumin"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0028778:Blocked [Pathologic Function]
   753   C0229671:Serum [Body Substance]
   753   C0332206:Blocked [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0036082:Saline [Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.108: Primary antibody (anti-c-myc, 9E10) was then added into the cultures at a dilution of 1:100 and maintained for 30 min at 4 C. 

Phrase: "Primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-c-myc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0432624:Anti C [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0432626:Anti c [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "9E10"

Phrase: ")"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added into the cultures"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0010453:Cultures [Idea or Concept]
   770   C1524062:Added [Functional Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C1883712:Add [Functional Concept]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "at a dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "of 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: "and"

Phrase: "maintained for 30 min"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]

Phrase: "at 4 C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.109: The cells were extensively washed with PBS before introducing peroxidase-conjugated rabbit anti-mouse IgG (1:1000). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "extensively"

Phrase: "washed with PBS"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C1441704:Prewarmed [Laboratory Procedure]
   753   C1548982:Washed [Idea or Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   719 E C0441648:Wash [Activity]

Phrase: "before introducing peroxidase-conjugated rabbit anti-mouse IgG (1"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   822   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0025914:Mouse [Mammal]
   793   C0025929:mouse [Mammal]
   793   C0026809:Mouse [Mammal]
   793   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0034493:Rabbit [Mammal]
   793   C0522529:Conjugated [Spatial Concept]
   793   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   760   C1292748:introduce [Functional Concept]
   721 E C1160466:conjugation [Cell Function]

Phrase: ":"

Phrase: "1000"

Phrase: ")."
Processing 00000000.tx.110: After 30 min at 4 C, the cells were extensively washed, and 1 ml of O-phenylenediamine dihydrochloride reagent (0.4 mg/ml O-phenylenediamine dihydrochloride and 0.4 mg/ml urea hydrogen peroxide in 0.05 M phosphate/citrate) was added to each well for 10 min at room temperature. 

Phrase: "After 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "extensively"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "1 ml of O-phenylenediamine dihydrochloride reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439526:/mL [Quantitative Concept]

Phrase: "(0.4 mg/ml O-phenylenediamine dihydrochloride"

Phrase: "and"

Phrase: "0.4 mg/ml urea hydrogen peroxide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   845   C0108342:Urea hydrogen peroxide [Organic Chemical,Pharmacologic Substance]
           Urea peroxide
   818   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0020275:Hydrogen [Element, Ion, or Isotope]
   795   C0031180:Peroxide [Inorganic Chemical]
   795   C0523702:HYDROGEN [Laboratory Procedure]
   795   C0885426:hydrogen [Inorganic Chemical]

Phrase: "in 0.05 M phosphate/citrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0008857:Citrate [Organic Chemical]
   804   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "added to each well"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1883712:Add [Functional Concept]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.111: The reaction was stopped by the addition of 0.25 ml of 3 N HCl. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by the addition of 0.25 ml of 3 N HCl."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   736   C0439526:/mL [Quantitative Concept]
   736   C1272691:stopped [Qualitative Concept]
   736   C1883712:Addition [Functional Concept]
   703 E C1947925:Stop [Activity]
   703 E C2746065:Stop [Temporal Concept]
Processing 00000000.tx.112: The supernatant was collected and the optical absorbance was measured at 492 nm. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "the optical absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1268822:Absorbance [Clinical Attribute]
   861   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "measured at 492 nm."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.113: For phosphoprotein analysis, total cell lysates were prepared as described previously with modifications (44). 

Phrase: "For phosphoprotein analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "total cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously with modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0392747:Modification [Functional Concept]
   756   C1554963:modification [Qualitative Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.114: Following appropriate incubation in the presence or absence of insulin (100 nM), cells were lysed on ice with 150 M 2x Laemmli sample buffer supplemented with 7.5% -mercaptoethanol, phosphatase inhibitors (1 mM Na2VO4 and 100 nM okadaic acid), and protease inhibitors (1 mM benzamidine, 0.2 mM phenylmethylsulfonyl fluoride, 10 M E-64, 1 M pepstatin A, and 1 M leupeptin), passed five times through a 24-gauge syringe, and heated for 15 min at 65 C. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "appropriate incubation in the presence"

Phrase: "or"

Phrase: "absence of insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(100 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C0024348:lysed [Pathologic Function]

Phrase: "with 150 M 2x Laemmli sample buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0258024:Laemmli buffer [Organic Chemical]
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "supplemented with 7.5% -mercaptoethanol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025402:Mercaptoethanol [Organic Chemical]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "phosphatase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(1 mM Na2VO4"

Phrase: "and"

Phrase: "100 nM okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(1 mM benzamidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "0.2 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 M E-64,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "1 M pepstatin A,"

Phrase: "and"

Phrase: "1 M leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "passed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828386:Passed [Finding]

Phrase: "five times through a 24-gauge syringe,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "heated for 15 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   737   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "at 65 C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.115: Total protein (50 g) was resolved by SDS-PAGE and immunoblotted with the respective phosphospecific antibody. 

Phrase: "Total protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "(50 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "immunoblotted with the respective phosphospecific antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1257988:Phosphospecific Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.116: Statistical AnalysisValues are expressed as the mean  S.E. 

Phrase: "Statistical AnalysisValues"

Phrase: "are"

Phrase: "expressed as the mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.117: Where applicable, the significance of difference was analyzed using Student's t test for unpaired data.  

Phrase: "Where applicable,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1272460:applicable [Qualitative Concept]
   861   C1706839:Applicable [Qualitative Concept]

Phrase: "the significance of difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Student's t test for unpaired data."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   820   C1710574:Unpaired t-Test [Intellectual Product]
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:student [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C1551041:student [Idea or Concept]
   753   C1552573:student [Intellectual Product]
Processing 00000000.tx.118: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Long term treatment with low doses of EtBr is known to selectively inhibit mtDNA replication and transcription without detectable changes in nuclear DNA (2426). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Long term treatment with low doses of EtBr"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0023977:long-term treatment [Health Care Activity]
   773   C1708745:Low-Dose Treatment [Research Activity]
   742   C0039798:treatment [Functional Concept]
   742   C0087111:Treatment [Therapeutic or Preventive Procedure]
   742   C1522326:Treatment [Functional Concept]
   742   C1533734:Treatment [Therapeutic or Preventive Procedure]
   742   C1705169:Treatment [Conceptual Entity]
   742   C3538994:TREATMENT [Research Activity]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to selectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "mtDNA replication"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1326316:mitochondrial DNA replication [Genetic Function]
   901   C0598312:DNA Replication [Genetic Function]
           Replication
   901   C2984261:DNA replication [Functional Concept]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "transcription without detectable changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "in nuclear DNA (2426"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521447:Nuclear [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.119: In a recent study, mtDNA of the C2C12 muscle cell line was partially depleted by long term exposure to EtBr, and the reversal of mtDNA depletion was successfully achieved by removal of EtBr (28). 

Phrase: "In a recent study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "mtDNA of the C2C12 muscle cell line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1819717:mitochondrial DNA [Cell Component]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0521451:Mitochondrial [Functional Concept]

Phrase: "was"

Phrase: "partially"

Phrase: "depleted by long term exposure"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0443252:Long-term [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]
   760   C0333668:Depleted [Functional Concept]
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C2826302:TERM [Intellectual Product]

Phrase: "to EtBr,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the reversal of mtDNA depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443290:Reversal [Functional Concept]

Phrase: "was"

Phrase: "successfully"

Phrase: "achieved by removal of EtBr"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   753   C0006222:Bromide [Inorganic Chemical]
   753   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.120: The ability to partially deplete and replete the cellular mtDNA levels in cell lines by EtBr treatment would allow one to study cellular processes affected by changes in mtDNA content. 

Phrase: "The ability to partially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "and"

Phrase: "replete"

Phrase: "the cellular mtDNA levels in cell lines by EtBr treatment"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0007600:Cell lines [Cell]
   736   C0205132:lines [Spatial Concept]
   703 E C1550648:Line [Substance]
   703 E C1552960:Line [Quantitative Concept]

Phrase: "would"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "one to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "cellular processes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0007613:Cellular Process [Cell Function]
   983   C1325880:cellular process [Cell Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "affected by changes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0392747:changes [Functional Concept]
   790   C0392760:Affected [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in mtDNA content."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]
Processing 00000000.tx.121: To develop partially mtDNA-depleted muscle cell lines, we exposed L6 GLUT4myc myocytes to EtBr (0.2 g/ml) in Dulbecco's modified Eagle's medium supplemented with pyruvate and uridine, previously shown to be essential for the growth of mtDNA-depleted cells (27). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "partially mtDNA-depleted muscle cell lines,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   818   C0007600:Cell lines [Cell]
   795   C0205132:lines [Spatial Concept]
   762 E C1550648:Line [Substance]
   762 E C1552960:Line [Quantitative Concept]

Phrase: "we"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "L6 GLUT4myc myocytes to EtBr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596981:Myocytes [Cell]

Phrase: "(0.2 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "ml) in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "supplemented with pyruvate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0034354:pyruvate [Organic Chemical]
   790   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "uridine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041984:Uridine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "essential for the growth of mtDNA-depleted cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205224:Essential [Qualitative Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.122: The mtDNA content from L6 GLUT4myc myocytes cultured with or without EtBr was monitored routinely by amplifying genomic DNA as described under "Experimental Procedures." 

Phrase: "The mtDNA content from L6 GLUT4myc myocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]

Phrase: "cultured with"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C2242979:Culture [Laboratory Procedure]

Phrase: "or without EtBr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   770   C0006222:Bromide [Inorganic Chemical]
   770   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "routinely by amplifying genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0017428:Genomic [Gene or Genome]
   760   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.123: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.124: 1, A and B, shows that cytochrome oxidase subunits I (COX I) and II (COX II), which are encoded only in mtDNA, were hardly amplified from the genomic DNA of the cells treated with EtBr for 3 weeks. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that cytochrome oxidase subunits I (COX I"

Phrase: ")"

Phrase: "and"

Phrase: "II"

Phrase: "(COX II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1565860:COX-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705323:COX-2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "only in mtDNA,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0205171:Only [Quantitative Concept]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "were"

Phrase: "hardly"

Phrase: "amplified from the genomic DNA of the cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0007634:Cells [Cell]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017428:Genomic [Gene or Genome]
   744   C0887950:genomic [Biomedical Occupation or Discipline]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "treated with EtBr"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0006222:Bromide [Inorganic Chemical]
   770   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for 3 weeks."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442462:3 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.125: In contrast, nuclear DNA-encoded controls such as COX IV (Fig. 1) and -actin (data not shown) were equally detected in both control and EtBr-treated cells, indicating that prolonged treatment with EtBr partially depleted mtDNA without altering the nuclear DNA replication in L6 GLUT4myc myocytes. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "nuclear DNA-encoded controls such as COX IV (Fig. 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   706   C0243148:control [Qualitative Concept]
   706   C1550141:Control [Substance]
   706   C1882979:Control [Conceptual Entity]
   706   C2587213:Control [Functional Concept]
   706   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and -"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "equally"

Phrase: "detected in both control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "EtBr-treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "indicating"

Phrase: "that prolonged treatment with EtBr partially"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "mtDNA without altering"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "the nuclear DNA replication in L6 GLUT4myc myocytes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0598312:DNA Replication [Genetic Function]
           Replication
   770   C2984261:DNA replication [Functional Concept]
   744   C1883725:replication [Qualitative Concept]
Processing 00000000.tx.126: Under these experimental conditions, mtDNA was depleted to 10% of normal cells after 3 weeks of growth in the presence of EtBr (Fig. 1A). 

Phrase: "Under these experimental conditions,"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "was"

Phrase: "depleted to 10% of normal cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   756   C0007634:Normal cell [Cell]
           Cells
   756   C1268443:Normal cell [Cell]
   753   C0205307:Normal [Qualitative Concept]
   753   C0333668:Depleted [Functional Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "after 3 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442462:3 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of EtBr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.127: In addition, the removal of EtBr from medium successfully normalized mtDNA content (90% of the normal cells) in this clone within 7 days (Fig. 1, A and B). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the removal of EtBr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "from medium successfully"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "mtDNA content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(90% of the normal cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   773   C0007634:Normal cell [Cell]
           Cells
   773   C1268443:Normal cell [Cell]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C2347086:% Normal [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "in this clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "within 7 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547085:7 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.128: In order to minimize the variability of mtDNA content between each experiment, we selected and propagated the single cell clone, whose mtDNA content was less than 5% of the control, and used cells from the same frozen stock for all of the experiments. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "minimize"

Phrase: "the variability of mtDNA content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827666:Variability [Conceptual Entity]

Phrase: "between each experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "and"

Phrase: "propagated"

Phrase: "the single cell clone,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0009013:Cell Clone [Cell]
           Clone
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "whose mtDNA content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "was"

Phrase: "less than 5% of the control,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0439092:Less Than [Intellectual Product]
           less
   753   C0243148:control [Qualitative Concept]
   753   C0547044:Less [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "used cells from the same frozen stock"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "for all"

Phrase: "of the experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.129: View larger version (17K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.130: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.131: mtDNA content. 

Phrase: "mtDNA content."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]
Processing 00000000.tx.132: A, genomic DNA was isolated from control (C), mtDNA-depleted (D), and mtDNA-reverted (R) L6 GLUT4myc myocytes, and mtDNA-encoded genes, such as COX I and COX II, and nuclear DNA-encoded gene, such as COX IV, were amplified by PCR. 

Phrase: "A,"

Phrase: "genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "isolated from control (C),"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0205409:Isolated [Functional Concept]
   790   C0243148:control [Qualitative Concept]
   790   C1548221:Isolated [Idea or Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "mtDNA-depleted (D),"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "mtDNA-reverted (R) L6 GLUT4myc myocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596981:Myocytes [Cell]

Phrase: "and"

Phrase: "mtDNA-encoded genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1563761:Genes, Mitochondrial [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]

Phrase: "such as COX I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "COX II,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1565860:COX-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705323:COX-2 [Gene or Genome]

Phrase: "and"

Phrase: "nuclear DNA-encoded gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "such as COX IV,"

Phrase: "were"

Phrase: "amplified by PCR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
Processing 00000000.tx.133: The PCR products were visualized on agarose gel after EtBr staining. 

Phrase: "The PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "visualized on agarose gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1706746:Agarose Gel [Research Device]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0036681:Agarose [Carbohydrate]
   770   C0234621:Visualized [Functional Concept]
   770   C1382104:Gel [Substance]

Phrase: "after EtBr staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.134: B, the DNA levels obtained by densitometry were normalized against -actin signals (data not shown), and relative intensities were expressed in arbitrary units where the intensity of control L6 GLUT4myc myocytes was set to 100%. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the DNA levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "obtained by densitometry"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "were"

Phrase: "normalized against -actin signals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1882115:Normalized [Research Activity]
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "relative intensities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:intensities [Qualitative Concept]

Phrase: "were"

Phrase: "expressed in arbitrary units where"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   773   C0439183:Arbitrary unit [Quantitative Concept]
   760   C0439148:Units [Quantitative Concept]
   760   C1264693:*Arbitrary [Quantitative Concept]
   760   C1519795:Units [Quantitative Concept]
   726 E C1704753:Unit [Manufactured Object]
   726 E C1880519:Unit [Quantitative Concept]

Phrase: "the intensity of control L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "set to 100%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.135: Data were analyzed by Student's t test. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by Student's t test."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0936012:Analyzed [Research Activity]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]
Processing 00000000.tx.136: All results represent mean  S.E. from eight independent experiments. 

Phrase: "All results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from eight independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.137: Open column, control; 

Phrase: "Open column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.138: closed column, mtDNA-depleted; 

Phrase: "closed column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "mtDNA-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ";"
Processing 00000000.tx.139: gray column, mtDNA-reverted; 

Phrase: "gray column,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0556636:gray [Quantitative Concept]
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1269776:Gray [Qualitative Concept]
   861   C1706132:Column [Idea or Concept]

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: ";"
Processing 00000000.tx.140: ***, p 0.001.  

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.141: In previous reports, the partial depletion of mtDNA reduced mitochondrial transmembrane potential, m, as measured with the mitochondria-specific cationic fluorescent dye Mitotracker (28, 30, 45, 46). 

Phrase: "In previous reports,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "the partial depletion of mtDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   753   C0333668:Depletion [Functional Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "mitochondrial transmembrane potential,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0025251:Transmembrane Potential [Cell Function]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   827   C3245505:Potential [Qualitative Concept]

Phrase: "m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "as"

Phrase: "measured with the mitochondria-specific cationic fluorescent dye Mitotracker"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   764   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]
   742   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   742   C0026237:Mitochondria [Cell Component]
   742   C0205369:Specific [Qualitative Concept]
   742   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0444706:Measured [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]

Phrase: "(28,"

Phrase: "30,"

Phrase: "45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.142: Since Mitotracker localizes in mitochondria in a m-dependent manner (40), the fluorescent intensity from living cells thoroughly reflects the integrity of mitochondrial function. 

Phrase: "Since"

Phrase: "Mitotracker"

Phrase: "localizes in mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C0392752:localize [Spatial Concept]

Phrase: "in a m-dependent manner"

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "the fluorescent intensity from living cells thoroughly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the integrity of mitochondrial function."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]
Processing 00000000.tx.143: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.144: 2A, control cells exhibited granule-like fluorescence dispersed in the cytoplasm, whereas the mtDNA-depleted cells showed drastically reduced fluorescence intensity, suggesting that the depletion of mtDNA disrupted m in L6 GLUT4myc myocytes. 

Phrase: "2A,"

Phrase: "control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "granule-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0010837:Granule [Cell Component]
  1000   C0993609:Granule [Biomedical or Dental Material]
   928 E C0205248:Granular [Qualitative Concept]

Phrase: "like fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "dispersed in the cytoplasm,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0332624:Dispersed [Spatial Concept]

Phrase: "whereas"

Phrase: "the mtDNA-depleted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "drastically reduced fluorescence intensity,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0522510:Intensity [Qualitative Concept]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the depletion of mtDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   926   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   760   C0333668:Depletion [Functional Concept]

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "m in L6 GLUT4myc myocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.145: On the other hand, the reverted cells nearly regained the fluorescence intensity of control cells, indicating that mitochondrial membrane potential was nearly restored in the reverted cells. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the reverted cells nearly"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "regained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1875723:REGAIN [Food]

Phrase: "the fluorescence intensity of control cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0522510:Intensity [Qualitative Concept]

Phrase: "indicating"

Phrase: "that mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "nearly"

Phrase: "restored in the reverted cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.146: As expected from the depletion of mtDNA content and mitochondrial membrane potential, the depleted cells showed drastically reduced total cellular ATP as compared with control cells (Fig. 2B). 

Phrase: "As"

Phrase: "expected from the depletion of mtDNA content"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   770   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1819717:mitochondrial DNA [Cell Component]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0333668:Depletion [Functional Concept]
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C1517001:Expected [Idea or Concept]

Phrase: "and"

Phrase: "mitochondrial membrane potential,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "the depleted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "drastically"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "total cellular ATP"

Phrase: "as"

Phrase: "compared with control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0007634:Cells [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.147: Following mtDNA repletion, total cellular ATP content of the reverted cells was not significantly different from that of control cells (Fig. 2B). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "mtDNA repletion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "total cellular ATP content of the reverted cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "not significantly different from that of control cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.148: View larger version (30K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.149: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.150: Fluorescence microscopic characterization and ATP content in control, mtDNA-depleted, and mtDNA-reverted L6 GLUT4myc myocytes. 

Phrase: "Fluorescence microscopic characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "ATP content in control,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "mtDNA-depleted,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "mtDNA-reverted L6 GLUT4myc myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596981:Myocytes [Cell]
Processing 00000000.tx.151: A, control, mtDNA-depleted, and mtDNA-reverted L6 GLUT4myc myocytes were stained with MitoTracker Green, a mitochondrial membrane potential dye, as described under "Experimental Procedures." 

Phrase: "A,"

Phrase: "control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "mtDNA-depleted,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "mtDNA-reverted L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596981:Myocytes [Cell]

Phrase: "were"

Phrase: "stained with MitoTracker Green,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332583:Green [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "a mitochondrial membrane potential dye,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   756   C1720920:Membrane Potential, Mitochondrial [Cell Function]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.152: Magnification is x400. 

Phrase: "Magnification"

Phrase: "is"

Phrase: "x400."
Processing 00000000.tx.153: B, total cellular ATP levels were measured by the luciferin-luciferase assay as described under "Experimental Procedures." 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "total cellular ATP levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by the luciferin-luciferase assay"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0024076:luciferin [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0243073:assay [Qualitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.154: ATP content was expressed in arbitrary units, where the ATP content from control L6 GLUT4myc myocytes was set to 100%. 

Phrase: "ATP content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "expressed in arbitrary units,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "where"

Phrase: "the ATP content from control L6 GLUT4myc myocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "set to 100%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.155: Data were analyzed by Student's t test. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by Student's t test."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0936012:Analyzed [Research Activity]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]
Processing 00000000.tx.156: All results represent mean  S.E. from five independent experiments. 

Phrase: "All results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from five independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.157: Open column, control; 

Phrase: "Open column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.158: closed column, mtDNA-depleted; 

Phrase: "closed column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "mtDNA-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ";"
Processing 00000000.tx.159: gray column, mtDNA-reverted; 

Phrase: "gray column,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0556636:gray [Quantitative Concept]
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1269776:Gray [Qualitative Concept]
   861   C1706132:Column [Idea or Concept]

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: ";"
Processing 00000000.tx.160: ***, p 0.001.  

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.161: We next analyzed the differential expressions of mitochondrial and nuclear genes such as COX I, II, and IV by qRT-PCR in the control, mtDNA-depleted, and mtDNA-reverted cells (Fig. 3, A and B). 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the differential expressions of mitochondrial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:expressions [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "nuclear genes such as COX I,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Genes [Gene or Genome]

Phrase: "II,"

Phrase: "and"

Phrase: "IV by qRT-PCR"

Phrase: "in the control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "mtDNA-depleted,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "mtDNA-reverted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.162: -Actin used as a control was not changed by mtDNA content alteration by RT-PCR (data not shown). 

Phrase: "-Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "used as a control"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "changed by mtDNA content alteration"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1819717:mitochondrial DNA [Cell Component]
   783   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   783   C0596611:DNA Alteration [Genetic Function]
   783   C2267112:DNA Alteration [Cell Function]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0392747:Changed [Functional Concept]
   753   C0423896:Content [Mental Process]
   753   C0443172:Changed [Quantitative Concept]
   753   C0456205:Content [Conceptual Entity]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1515926:Alteration [Idea or Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "by RT-PCR (data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.163: The mtDNA-depleted cells contained very small amounts of COX I and II mRNAs, which are mtDNA-encoded genes, whereas the reverted cells showed a similar amount of COX I and II mRNAs as control cells. 

Phrase: "The mtDNA-depleted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "very small amounts of COX I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "II mRNAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "are"

Phrase: "mtDNA-encoded genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1563761:Genes, Mitochondrial [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]

Phrase: "whereas"

Phrase: "the reverted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a similar amount of COX I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "II mRNAs as control cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.164: However, mRNA content of COX IV, which are encoded by nuclear DNA, were not changed in the depleted and reverted cells, suggesting that mitochondrial mRNA levels correspond to the cellular mtDNA contents in these cells. 

Phrase: "However,"

Phrase: "mRNA content of COX IV,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "which"

Phrase: "are"

Phrase: "encoded by nuclear DNA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0521447:Nuclear [Spatial Concept]
   770   C0679058:encoded [Mental Process]
   770   C2700640:Encoded [Activity]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "changed in the depleted"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0333668:Depleted [Functional Concept]
   770   C0392747:Changed [Functional Concept]
   770   C0443172:Changed [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "reverted cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that mitochondrial mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0066598:mRNA, mitochondrial [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "correspond to the cellular mtDNA contents"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C1819717:mitochondrial DNA [Cell Component]
   748   C0007634:Cellular [Cell]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0178539:Cellular [Functional Concept]
   748   C0456205:Contents [Conceptual Entity]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1552853:contents [Idea or Concept]
   714 E C0423896:Content [Mental Process]

Phrase: "in these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.165: View larger version (17K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.166: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.167: Analysis of mRNAs transcribed from mtDNA and nuclear DNA. 

Phrase: "Analysis of mRNAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "transcribed from mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1819717:mitochondrial DNA [Cell Component]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "nuclear DNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521447:Nuclear [Spatial Concept]
Processing 00000000.tx.168: A, total RNA was extracted from control (C), mtDNA-depleted (D), and mtDNA-reverted (R) L6 GLUT4myc myocytes, and mtDNA-encoded transcripts, such as COX I and COX III, and nuclear DNA-encoded transcript, such as COX IV, were analyzed by RT-PCR and visualized on agarose gel. 

Phrase: "A,"

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from control"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "(C"

Phrase: ")"

Phrase: ","

Phrase: "mtDNA-depleted"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(D"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(R"

Phrase: ")"

Phrase: "L6 GLUT4myc myocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "and"

Phrase: "mtDNA-encoded transcripts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "such as COX I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "COX III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "nuclear DNA-encoded transcript,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "such as COX IV,"

Phrase: "were"

Phrase: "analyzed by RT-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "visualized on agarose gel."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1706746:Agarose Gel [Research Device]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0036681:Agarose [Carbohydrate]
   770   C0234621:Visualized [Functional Concept]
   770   C1382104:Gel [Substance]
Processing 00000000.tx.169: B, in order to confirm transcript levels, quantitative real time RT-PCR (qRT-PCR) was carried out as described under "Experimental Procedures." 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "transcript levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0441889:Levels [Qualitative Concept]
   861   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "quantitative real time RT-PCR"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   911   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   888   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: "(qRT-PCR"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   911   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   888   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.170: The CT method was used to analyze the data by generating relative values of the amount of target cDNA. 

Phrase: "The CT method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the data by generating relative values of the amount of target cDNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C1511726:Data [Idea or Concept]
   736   C3245479:data [Medical Device]
   734   C1704610:Data Value [Intellectual Product]
Processing 00000000.tx.171: The relative values were expressed in arbitrary units, where the intensity of control L6 GLUT4myc myocytes was set to 100%. 

Phrase: "The relative values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0205345:Relative Value [Qualitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "expressed in arbitrary units,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "where"

Phrase: "the intensity of control L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "set to 100%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.172: Data were analyzed by Student's t test. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by Student's t test."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0936012:Analyzed [Research Activity]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]
Processing 00000000.tx.173: All results represent mean  S.E. from five independent experiments. 

Phrase: "All results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from five independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.174: Open column, control; 

Phrase: "Open column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.175: closed column, mtDNA-depleted; 

Phrase: "closed column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "mtDNA-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ";"
Processing 00000000.tx.176: gray column, mtDNA-reverted; 

Phrase: "gray column,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0556636:gray [Quantitative Concept]
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1269776:Gray [Qualitative Concept]
   861   C1706132:Column [Idea or Concept]

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: ";"
Processing 00000000.tx.177: ***, p 0.001.  

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.178: In previous reports, the quantitative analysis of mtDNA revealed that the decrease of mtDNA content is associated with diabetes in animals and human subjects (2123). 

Phrase: "In previous reports,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "the quantitative analysis of mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0200898:DNA analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0392762:Quantitative [Quantitative Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the decrease of mtDNA content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "associated with diabetes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "human subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0178693:human subjects [Research Activity]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(2123"

Phrase: ")."
Processing 00000000.tx.179: To demonstrate how the depletion and repletion of mtDNA content in L6 GLUT4myc myocytes correlate with glucose transport activity, we measured 2DG uptake in the control, mtDNA-depleted, and mtDNA-reverted cells (Fig. 4A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "how"

Phrase: "the depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333668:Depletion [Functional Concept]

Phrase: "and"

Phrase: "repletion of mtDNA content"

Phrase: "in L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "correlate with glucose transport activity,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0178666:glucose transport [Cell Function]
   762   C0005529:Active Transport [Physiologic Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1317949:Transport [Manufactured Object]
   760   C1561536:*Activity [Idea or Concept]
   760   C3495449:transport [Medical Device]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "2DG uptake in the control,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "mtDNA-depleted,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "mtDNA-reverted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.180: Insulin stimulation (100 nM, 20 min at 37 C) increased 2DG uptake by 1.95-fold as compared with the basal state in control cells, whereas there was a significant (62%) reduction in the basal state 2DG uptake from the mtDNA-depleted cells. 

Phrase: "Insulin stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(100 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "20 min at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2DG uptake by 1.95-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]

Phrase: "as"

Phrase: "compared with the basal state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205112:Basal [Spatial Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1707455:Compared [Activity]
   760   C3148680:State [Geographic Area]

Phrase: "in control cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "there"

Phrase: "was"

Phrase: "a significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "(62%"

Phrase: ")"

Phrase: "reduction in the basal state 2DG uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "from the mtDNA-depleted cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.181: Moreover, insulin-stimulated increase in 2DG uptake was not observed in these cells, indicating that mtDNA depletion in L6 GLUT4myc myocytes provoked impaired glucose utilization and insulin resistance. 

Phrase: "Moreover,"

Phrase: "insulin-stimulated increase in 2DG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0020459:INSULIN INCREASE [Disease or Syndrome]
   748   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in these cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "indicating"

Phrase: "that mtDNA depletion in L6 GLUT4myc myocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   744   C0333668:Depletion [Functional Concept]

Phrase: "provoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Provoked [Qualitative Concept]

Phrase: "impaired glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.182: Interestingly, when the mtDNA content was returned to nearly control level in the reverted cells, 2DG uptake in the presence or absence of insulin stimulation was dramatically restored to that of the control. 

Phrase: "Interestingly,"

Phrase: "when"

Phrase: "the mtDNA content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "was"

Phrase: "returned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332156:Return [Qualitative Concept]

Phrase: "to nearly control level in the reverted cells,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0243148:control [Qualitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2946261:Level [Pharmacologic Substance]
   744   C3274648:Control [Qualitative Concept]

Phrase: "2DG uptake in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "or"

Phrase: "absence of insulin stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "was"

Phrase: "dramatically"

Phrase: "restored to that of the control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.183: To confirm that the reduced 2DG uptake in mtDNA-depleted cells is indeed due to a reduced trans-membrane glucose transport rather than a decreased glucose phosphorylation due to the reduced ATP level, we also measured the uptake of nonmetabolizable glucose analogue, 3OMG (Fig. 4B), and obtained results similar to those of 2DG uptake, clearly indicating that the glucose transport step was affected by the reduction of mtDNA in L6 GLUT4myc myocytes. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the reduced 2DG uptake in mtDNA-depleted cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0243144:Uptake [Physiologic Function]
   739   C0347980:% uptake [Quantitative Concept]

Phrase: "is"

Phrase: "indeed due to a reduced trans-membrane glucose transport"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C0178666:glucose transport [Cell Function]
   764   C0678226:Due to [Functional Concept]
           due
   762   C1519624:Membrane Transport [Cell Function]
   762   C1550030:Transport To [Idea or Concept]
   742   C0005528:Transport, NOS [Cell Function]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0025255:Membrane [Tissue]
   742   C0392756:Reduced [Qualitative Concept]
   742   C0596901:Membrane [Cell Component]
   742   C1317949:Transport [Manufactured Object]
   742   C1706182:Membrane [Manufactured Object]
   742   C2826298:TRANS [Idea or Concept]
   742   C3146286:Due [Idea or Concept]
   742   C3495449:transport [Medical Device]

Phrase: "rather than"

Phrase: "a decreased glucose phosphorylation due to the reduced ATP level,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "we also"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the uptake of nonmetabolizable glucose analogue,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159527:glucose uptake [Cell Function]
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "3OMG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047666:3-O-Methylglucose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "similar to those of 2DG uptake,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "clearly"

Phrase: "indicating"

Phrase: "that"

Phrase: "the glucose transport step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]
   734   C0178666:glucose transport [Cell Function]

Phrase: "was"

Phrase: "affected by the reduction of mtDNA"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C1819717:mitochondrial DNA [Cell Component]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0392760:Affected [Functional Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1314939:Affected [Functional Concept]
   714 E C0001721:Affect [Mental Process]

Phrase: "in L6 GLUT4myc myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]
Processing 00000000.tx.184: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.185: 4. 

Phrase: "4."
Processing 00000000.tx.186: Effect of mtDNA content changes on glucose uptake. 

Phrase: "Effect of mtDNA content changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.187: Control, mtDNA-depleted (Depleted), and mtDNA-reverted (Reverted) L6 GLUT4myc myocytes were starved of serum for 5 h and washed twice with Hepes-buffered saline solution. 

Phrase: "Control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "mtDNA-depleted"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(Depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(Reverted"

Phrase: ")"

Phrase: "L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "were"

Phrase: "starved of serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   756   C2348531:Starve [Activity]

Phrase: "for 5 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with Hepes-buffered saline solution."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0036082:Saline Solution [Substance]
           Saline
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.188: Cells were incubated for 20 min in the presence or absence of insulin (100 nM at 37 C), and then 2DG (for 3 min with 10 M [14C]2DG) (A) and 3OMG (for 15 s with 50 M [14C]3OMG) (B) uptakes were measured as described under "Experimental Procedures." 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 20 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(100 nM at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then 2DG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0011501:Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: "for 3 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "with 10"

Phrase: "M ["

Phrase: "14C"

Phrase: "]2DG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]
           Deoxyglucose

Phrase: ")"

Phrase: "(A)"

Phrase: "and"

Phrase: "3OMG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047666:3-O-Methylglucose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "for 15 s"

Phrase: "with 50"

Phrase: "M ["

Phrase: "14C"

Phrase: "]3OMG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047666:3-O-Methylglucose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "(B) uptakes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243144:uptakes [Physiologic Function]
   827 E C0347980:% uptake [Quantitative Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.189: Values were expressed as means  S.E. from five independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "expressed as means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1704970:Means [Conceptual Entity]
   756 E C0444504:Mean [Quantitative Concept]
   756 E C2347634:Mean [Quantitative Concept]
   756 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from five independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.190: Open column, basal state; 

Phrase: "Open column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "basal state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205112:Basal [Spatial Concept]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: ";"
Processing 00000000.tx.191: closed column, insulin-stimulated state; 

Phrase: "closed column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "insulin-stimulated state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: ";"
Processing 00000000.tx.192: ***, p 0.001; 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.193: **, p 0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "p 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.194: *, p 0.05.  

Phrase: "*,"

Phrase: "p 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.195: It has been reported that basal and insulin-stimulated glucose uptake in insulin sensitive tissues, such as muscle and adipocytes, mainly correlates with the amount of GLUT4 in the PM (10, 47). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated glucose uptake in insulin sensitive tissues,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1159527:glucose uptake [Cell Function]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]

Phrase: "such as muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "adipocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "mainly"

Phrase: "correlates with the amount of GLUT4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1265611:Amount [Quantitative Concept]
   753   C1420175:GLUT4 [Gene or Genome]
   753   C2982484:GLUT4 [Gene or Genome]

Phrase: "in the PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(10,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.196: Since basal glucose uptake was significantly decreased by mtDNA depletion (Fig. 4), we next assessed whether the reduction of mtDNA content in L6 GLUT4myc myocytes is associated with impaired GLUT4 expression. 

Phrase: "Since"

Phrase: "basal glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159527:glucose uptake [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased by mtDNA depletion"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0333668:Depletion [Functional Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "whether"

Phrase: "the reduction of mtDNA content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "is"

Phrase: "associated with impaired GLUT4 expression."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1420175:GLUT4 [Gene or Genome]
   760   C2982484:GLUT4 [Gene or Genome]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.197: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.198: 5A, total cellular GLUT4 contents were not affected by mtDNA alteration and not significantly different among the control, depleted, and reverted cells. 

Phrase: "5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: "total cellular GLUT4 contents"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0456205:Contents [Conceptual Entity]
   812   C1552853:contents [Idea or Concept]
   779 E C0423896:Content [Mental Process]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by mtDNA alteration"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C0596611:DNA Alteration [Genetic Function]
   806   C1819717:mitochondrial DNA [Cell Component]
   806   C2267112:DNA Alteration [Cell Function]
   797   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0392760:Affected [Functional Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1515926:Alteration [Idea or Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "not significantly different among the control,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ","

Phrase: "and"

Phrase: "reverted cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.199: However, PM GLUT4 in the basal state of mtDNA-depleted cells was decreased by 4060% of control level, whereas repletion of mtDNA normalized PM GLUT4 content (Fig. 5, A and B), indicating that mtDNA depletion may interfere with basal GLUT4 targeting or recycling in L6 GLUT4myc myocytes. 

Phrase: "However,"

Phrase: "PM GLUT4 in the basal state of mtDNA-depleted cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C1420175:GLUT4 [Gene or Genome]
   736   C2982484:GLUT4 [Gene or Genome]

Phrase: "was"

Phrase: "decreased by 4060% of control level,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   753   C0205216:Decreased [Quantitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C2946261:Level [Pharmacologic Substance]
   753   C3274648:Control [Qualitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "whereas"

Phrase: "repletion of mtDNA"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "PM GLUT4 content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that mtDNA depletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   827   C0333668:Depletion [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "may"

Phrase: "interfere with basal GLUT4 targeting"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205112:Basal [Spatial Concept]
   760   C0521102:Interfere [Qualitative Concept]
   760   C1420175:GLUT4 [Gene or Genome]
   760   C1521840:Targeting [Functional Concept]
   760   C2982484:GLUT4 [Gene or Genome]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "or"

Phrase: "recycling in L6 GLUT4myc myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0282114:Recycling [Human-caused Phenomenon or Process]
Processing 00000000.tx.200: It is most likely that the reduced basal 2DG uptake observed in the depleted cells may result from the reduction of PM GLUT4 level as compared with control and reverted cells. 

Phrase: "It"

Phrase: "is"

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the reduced basal 2DG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0243144:Uptake [Physiologic Function]
   804   C0347980:% uptake [Quantitative Concept]

Phrase: "observed in the depleted cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0333668:Depleted [Functional Concept]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "result from the reduction of PM GLUT4 level"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   764   C0007603:Plasma membrane [Cell Component]
   742   C0025255:Membrane [Tissue]
   742   C0032105:Plasma [Body Substance]
   742   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C0596901:Membrane [Cell Component]
   742   C1274040:Result [Functional Concept]
   742   C1420175:GLUT4 [Gene or Genome]
   742   C1546471:Result [Idea or Concept]
   742   C1547707:Level [Geographic Area]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1706182:Membrane [Manufactured Object]
   742   C2825142:Result [Finding]
   742   C2946261:Level [Pharmacologic Substance]
   742   C2982484:GLUT4 [Gene or Genome]

Phrase: "as"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "reverted cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.201: Insulin stimulation substantially (about 2-fold) increased GLUT4 translocation to the PM in control cells (Fig. 5, A and B). 

Phrase: "Insulin stimulation substantially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(about 2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "increased GLUT4 translocation to the PM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040715:Translocation [Cell or Molecular Dysfunction]
   748   C2987521:Translocation [Activity]

Phrase: "in control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.202: In the depleted cells, however, with the accompanying reduction in PM GLUT4 content, insulin-stimulated GLUT4 translocation was largely (more than 80%) obliterated (Fig. 5, A and B), indicating that depletion of the cellular mtDNA is closely associated with the development of insulin resistance in L6 GLUT4myc myocytes. 

Phrase: "In the depleted cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "however,"

Phrase: "with the accompanying reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in PM GLUT4 content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "insulin-stimulated GLUT4 translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040715:Translocation [Cell or Molecular Dysfunction]
   812   C2987521:Translocation [Activity]

Phrase: "was"

Phrase: "largely"

Phrase: "(more than 80%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205172:More [Functional Concept]

Phrase: ")"

Phrase: "obliterated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700134:Obliterated [Functional Concept]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that depletion of the cellular mtDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   748   C0333668:Depletion [Functional Concept]

Phrase: "is"

Phrase: "closely"

Phrase: "associated with the development of insulin resistance"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0237834:Resistance [Mental Process]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1514892:Resistance [Physiologic Function]
   748   C1527148:Development [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in L6 GLUT4myc myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]
Processing 00000000.tx.203: The insulin-stimulated GLUT4 translocation in the reverted cells was slightly lower than that of control cells, a change that was not statistically significant (Fig. 5B). 

Phrase: "The insulin-stimulated GLUT4 translocation in the reverted cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0040715:Translocation [Cell or Molecular Dysfunction]
   742   C2987521:Translocation [Activity]

Phrase: "was"

Phrase: "slightly lower than that of control cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "a change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "not statistically significant"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.204: View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.205: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.206: Effect of mtDNA content changes on the expression and insulin-stimulated translocation of GLUT4. 

Phrase: "Effect of mtDNA content changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "insulin-stimulated translocation of GLUT4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]
Processing 00000000.tx.207: Control (C), mtDNA-depleted (D), and mtDNA-reverted (R) L6 GLUT4myc myocytes were starved of serum for 5 h and washed twice with Hepes-buffered saline solution. 

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(C"

Phrase: ")"

Phrase: ","

Phrase: "mtDNA-depleted"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(D"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(R"

Phrase: ")"

Phrase: "L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "were"

Phrase: "starved of serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   756   C2348531:Starve [Activity]

Phrase: "for 5 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with Hepes-buffered saline solution."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0036082:Saline Solution [Substance]
           Saline
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.208: Cells were incubated for 20 min in the presence or absence of insulin (100 nM at 37 C) and washed twice with cold Hepes-buffered saline solution. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 20 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(100 nM at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with cold Hepes-buffered saline solution."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0036082:Saline Solution [Substance]
           Saline
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0037633:Solution [Substance]
   748   C0234192:Cold [Physiologic Function]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1720725:Twice [Intellectual Product]
   748   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.209: A, total and PM proteins were prepared as described under "Experimental Procedures." 

Phrase: "A,"

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "PM proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   983   C1179841:Plasma membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.210: 2 g of membrane protein were analyzed by SDS-PAGE and immunoblotting. 

Phrase: "2 g of membrane protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.211: The protein levels obtained by densitometry from immunoblot intensity were expressed in arbitrary units, where the intensity for control was set to 1. 

Phrase: "The protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "obtained by densitometry"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "from immunoblot intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "were"

Phrase: "expressed in arbitrary units,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "where"

Phrase: "the intensity for control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "set to 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.212: B, the movement of myc-tagged GLUT4 to the cell surface was measured by an antibody-coupled colorimetric assay as described under "Experimental Procedures." 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the movement of myc-tagged GLUT4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0026649:Movement [Organism Function]

Phrase: "to the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "was"

Phrase: "measured by an antibody-coupled colorimetric assay"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1948027:Coupled [Functional Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0010222:couple [Family Group]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.213: Values are expressed as mean  S.E. from three independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444504:Mean [Quantitative Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.214: Open column, basal state; 

Phrase: "Open column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "basal state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205112:Basal [Spatial Concept]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: ";"
Processing 00000000.tx.215: closed column, insulin-stimulated state; 

Phrase: "closed column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "insulin-stimulated state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: ";"
Processing 00000000.tx.216: ***, p 0.001.  

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.217: Since the expression of various nuclear DNA-encoded genes was affected by mtDNA depletion (28, 30, 45, 46), it is possible that the insulin resistance in the mtDNA-depleted cells observed above may result from alteration in the insulin signaling intermediates involved in GLUT4 translocation, including insulin receptor, IRS-1, PI3K, PDK-1, and their downstream effector, Akt2/PKB (48, 49). 

Phrase: "Since"

Phrase: "the expression of various nuclear DNA-encoded genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0017262:Gene Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "affected by mtDNA depletion"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0333668:Depletion [Functional Concept]
   760   C0392760:Affected [Functional Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "(28,"

Phrase: "30,"

Phrase: "45,"

Phrase: "46"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the insulin resistance in the mtDNA-depleted cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0021655:Insulin Resistance [Pathologic Function]
   764   C2700570:INSULIN RESISTANCE [Gene or Genome]
   745   C0030281:Insulin Cell [Cell]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0237834:Resistance [Mental Process]
   742   C1514892:Resistance [Physiologic Function]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]

Phrase: "observed above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1441672:Observed [Functional Concept]

Phrase: "may"

Phrase: "result from alteration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1274040:Result [Functional Concept]
   790   C1515926:Alteration [Idea or Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "in the insulin signaling intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "involved in GLUT4 translocation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1314939:Involved [Functional Concept]
   770   C1420175:GLUT4 [Gene or Genome]
   770   C2982484:GLUT4 [Gene or Genome]
   770   C2987521:Translocation [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "insulin receptor,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "IRS-1,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PDK-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "their downstream effector,"

Phrase: "Akt2/PKB"

Phrase: "(48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.218: We measured the steady-state levels of mRNA (Fig. 6, A and B) and protein of these insulin signaling intermediates (Fig. 6, C and D) by qRT-PCR and immunoblotting. 

Phrase: "We"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the steady-state levels of mRNA (Fig. 6,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0678587:steady state [Natural Phenomenon or Process]
   754   C0683927:state level [Spatial Concept]
   744   C0205361:Steady [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "protein of these insulin signaling intermediates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: "by qRT-PCR"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   911   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   888   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.219: Interestingly, the mRNA level of IRS-1 was markedly altered by the depletion in cellular mtDNA content, whereas the mRNA levels of insulin receptor, PI3K, PDK-1, and Akt2/PKB were not affected by the depletion and repletion of mtDNA (Fig. 6, A and B). 

Phrase: "Interestingly,"

Phrase: "the mRNA level of IRS-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0202098:Insulin level [Laboratory Procedure]
   767   C0428405:insulin level [Laboratory or Test Result]
   767   C0456947:Level 1 [Intellectual Product]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "altered by the depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333668:Depletion [Functional Concept]
   770   C0392747:Altered [Functional Concept]

Phrase: "in cellular mtDNA content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "whereas"

Phrase: "the mRNA levels of insulin receptor,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0202098:insulin levels [Laboratory Procedure]
   783   C0428405:insulin levels [Laboratory or Test Result]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PDK-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Akt2/PKB"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the depletion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0333668:Depletion [Functional Concept]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "repletion of mtDNA"

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.220: In the depleted cells, mRNA of IRS-1 was reduced by 76%, compared with control cells. 

Phrase: "In the depleted cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "mRNA of IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   716   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "was"

Phrase: "reduced by 76%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "compared with control cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0007634:Cells [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.221: A prominent and selective change in IRS-1 was also evident in the protein levels from the depleted cells (Fig. 6, C and D); 

Phrase: "A prominent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205402:Prominent [Qualitative Concept]

Phrase: "and"

Phrase: "selective change in IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "also evident in the protein levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   731   C0393009:evidence level [Finding]

Phrase: "from the depleted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.222: the expression level of IRS-1 was reduced by 90% in the mtDNA-depleted cells as compared with control cells. 

Phrase: "the expression level of IRS-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C3244092:expression level [Idea or Concept]
   767   C0202098:Insulin level [Laboratory Procedure]
   767   C0428405:insulin level [Laboratory or Test Result]
   767   C0456947:Level 1 [Intellectual Product]
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "reduced by 90%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0392756:Reduced [Qualitative Concept]
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]

Phrase: "in the mtDNA-depleted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared with control cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0007634:Cells [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.223: In contrast, protein expression of IRS-2, PI3K, PDK-1, and Akt2/PKB were not changed by mtDNA depletion and repletion. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "protein expression of IRS-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1171362:protein expression [Genetic Function]
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   713   C0381451:Insulin Receptor Substrate-2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PDK-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Akt2/PKB"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "changed by mtDNA depletion"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0333668:Depletion [Functional Concept]
   760   C0392747:Changed [Functional Concept]
   760   C0443172:Changed [Quantitative Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "repletion."
Processing 00000000.tx.224: The protein level of IRS-1 was not fully increased to the level of control cells in the reverted cells, the significance of which is not immediately clear. 

Phrase: "The protein level of IRS-1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   855   C0123658:insulin receptor substrate 1 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0428479:Protein level [Laboratory or Test Result]
   767   C0202098:Insulin level [Laboratory Procedure]
   767   C0428405:insulin level [Laboratory or Test Result]
   767   C0456947:Level 1 [Intellectual Product]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "increased to the level of control cells"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   748   C0007634:Cells [Cell]
   748   C0205217:Increased [Quantitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2946261:Level [Pharmacologic Substance]
   748   C3274648:Control [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "in the reverted cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the significance of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "is"

Phrase: "not immediately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205548:Immediately [Temporal Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.225: We also checked whether the mRNA levels of several proteins thought to be involved in insulin-stimulated GLUT4 translocation are affected by mtDNA content changes. 

Phrase: "We also"

Phrase: "checked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Checked [Activity]

Phrase: "whether"

Phrase: "the mRNA levels of several proteins"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   750   C0428479:Protein level [Laboratory or Test Result]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in insulin-stimulated GLUT4 translocation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0040715:Translocation [Cell or Molecular Dysfunction]
   753   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1420175:GLUT4 [Gene or Genome]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2982484:GLUT4 [Gene or Genome]
   753   C2987521:Translocation [Activity]

Phrase: "are"

Phrase: "affected by mtDNA content changes."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1819717:mitochondrial DNA [Cell Component]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0392747:changes [Functional Concept]
   753   C0392760:Affected [Functional Concept]
   753   C0423896:Content [Mental Process]
   753   C0443172:changes [Quantitative Concept]
   753   C0456205:Content [Conceptual Entity]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   719 E C0001721:Affect [Mental Process]
   719 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.226: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.227: 7, the transcription levels of syntaxin 4, SNAP23, VAMP 2, and TC10 were not significantly different between the control, mtDNA-depleted, and mtDNA-reverted L6 GLUT4myc myocytes. 

Phrase: "7,"

Phrase: "the transcription levels of syntaxin 4,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0456950:Level 4 [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "SNAP23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420269:SNAP23 [Gene or Genome]

Phrase: "VAMP 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0148340:VAMP-2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VAMP-2 [Gene or Genome]
   861   C0279853:VAMP [Therapeutic or Preventive Procedure]
   861   C0635146:VAMP [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "TC10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425056:TC10 [Gene or Genome]

Phrase: "were"

Phrase: "not significantly different between the control,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "mtDNA-depleted,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "mtDNA-reverted L6 GLUT4myc myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596981:Myocytes [Cell]
Processing 00000000.tx.228: These results suggest that the expression of IRS-1, which is the insulin signaling molecule encoded by nuclear DNA, is selectively affected by the amount of cellular mtDNA in L6 GLUT4myc myocytes, and this change is most likely associated with insulin resistance developed in mtDNA-depleted cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the expression of IRS-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "the insulin signaling molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1519315:Signaling Molecule [Biologically Active Substance]
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "encoded by nuclear DNA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0521447:Nuclear [Spatial Concept]
   770   C0679058:encoded [Mental Process]
   770   C2700640:Encoded [Activity]

Phrase: "is"

Phrase: "selectively"

Phrase: "affected by the amount of cellular mtDNA"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1819717:mitochondrial DNA [Cell Component]
   744   C0007634:Cellular [Cell]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0178539:Cellular [Functional Concept]
   744   C0392760:Affected [Functional Concept]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C1265611:Amount [Quantitative Concept]
   744   C1314939:Affected [Functional Concept]
   711 E C0001721:Affect [Mental Process]

Phrase: "in L6 GLUT4myc myocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "and"

Phrase: "this change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "developed in mtDNA-depleted cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1819717:mitochondrial DNA [Cell Component]
   753   C0007634:Cells [Cell]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0333668:Depleted [Functional Concept]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.229: View larger version (48K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(48K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.230: 6. 

Phrase: "6."
Processing 00000000.tx.231: Effect of mtDNA content changes on insulin signaling pathway intermediates. 

Phrase: "Effect of mtDNA content changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin signaling pathway intermediates."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   779   C0205103:Intermediate [Spatial Concept]
   779   C1550465:intermediate [Idea or Concept]
   779   C2827755:INTERMEDIATE [Laboratory or Test Result]
   756   C1512804:Insulin Signaling Pathway [Molecular Function]
   756   C2984300:Insulin signaling pathway [Molecular Function]
   708   C2984427:Insulin Pathway [Functional Concept]
Processing 00000000.tx.232: A, total RNA from control, mtDNA-depleted (Depleted), and mtDNA-reverted (Reverted) L6 GLUT4myc myocytes was prepared as described under "Experimental Procedures." 

Phrase: "A,"

Phrase: "total RNA from control,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "mtDNA-depleted"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(Depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(Reverted"

Phrase: ")"

Phrase: "L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.233: Insulin receptor, IRS-1, PI3K, PDK-1, and Akt2/PKB mRNA levels were analyzed by RT-PCR and visualized on agarose gel. 

Phrase: "Insulin receptor,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "IRS-1,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PDK-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Akt2/PKB mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed by RT-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "visualized on agarose gel."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1706746:Agarose Gel [Research Device]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0036681:Agarose [Carbohydrate]
   770   C0234621:Visualized [Functional Concept]
   770   C1382104:Gel [Substance]
Processing 00000000.tx.234: B, in order to confirm transcript levels, qRT-PCR was carried out as described under "Experimental Procedures." 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "transcript levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0441889:Levels [Qualitative Concept]
   861   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "qRT-PCR"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   911   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   888   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.235: The comparative CT method was used to analyze the data by generating relative values of the amount of target cDNA. 

Phrase: "The comparative CT method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025663:Method [Intellectual Product]
   804   C0449851:Method [Functional Concept]
   804   C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the data by generating relative values of the amount of target cDNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C1511726:Data [Idea or Concept]
   736   C3245479:data [Medical Device]
   734   C1704610:Data Value [Intellectual Product]
Processing 00000000.tx.236: The relative values were expressed in arbitrary units, where the intensity of control L6 GLUT4myc myocytes was set to 100%. 

Phrase: "The relative values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0205345:Relative Value [Qualitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "expressed in arbitrary units,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "where"

Phrase: "the intensity of control L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "set to 100%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.237: C, a representative immunoblot of IRS-1, IRS-2, PI3K, PDK-1, Akt2/PKB, and -actin protein in control, mtDNA-depleted (Depleted), and mtDNA-reverted (Reverted) L6 GLUT4myc myocytes. 

Phrase: "C,"

Phrase: "a representative immunoblot of IRS-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "IRS-2,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0381451:Insulin Receptor Substrate-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334141:INSULIN RECEPTOR SUBSTRATE 2 [Gene or Genome]
  1000   C1334191:Insulin Receptor Substrate 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PDK-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Akt2/PKB,"

Phrase: "and -"

Phrase: "actin protein in control,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mtDNA-depleted"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(Depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(Reverted"

Phrase: ")"

Phrase: "L6 GLUT4myc myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]
Processing 00000000.tx.238: Total cell lysates (50 g) from each sample were subjected to immunoblot analysis using specific antibodies. 

Phrase: "Total cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(50 g) from each sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.239: D, the protein levels obtained by densitometry in control (C), mtDNA-depleted (D), and mtDNA-reverted (R) L6 GLUT4myc myocytes were normalized against -actin signals, and relative intensities were expressed in arbitrary units, where the intensity for control was set to 100%. 

Phrase: "D"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ","

Phrase: "the protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "obtained by densitometry"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(C"

Phrase: ")"

Phrase: ","

Phrase: "mtDNA-depleted"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(D"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(R"

Phrase: ")"

Phrase: "L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "were"

Phrase: "normalized against -actin signals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1882115:Normalized [Research Activity]
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "relative intensities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:intensities [Qualitative Concept]

Phrase: "were"

Phrase: "expressed in arbitrary units,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "where"

Phrase: "the intensity for control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "set to 100%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.240: Values are expressed as mean  S.E. from eight independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444504:Mean [Quantitative Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from eight independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.241: Open column, control; 

Phrase: "Open column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.242: closed column, mtDNA-depleted; 

Phrase: "closed column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "mtDNA-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ";"
Processing 00000000.tx.243: gray column, mtDNA-reverted; 

Phrase: "gray column,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0556636:gray [Quantitative Concept]
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1269776:Gray [Qualitative Concept]
   861   C1706132:Column [Idea or Concept]

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: ";"
Processing 00000000.tx.244: ***, p 0.001 versus control.  

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.245: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.246: 7. 

Phrase: "7."
Processing 00000000.tx.247: mRNA content of vesicle trafficking intermediates in control, mtDNA-depleted, and mtDNA-reverted L6 GLUT4myc myocytes. 

Phrase: "mRNA content of vesicle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "intermediates in control,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0205103:Intermediate [Spatial Concept]
   756   C1550465:intermediate [Idea or Concept]
   756   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "mtDNA-depleted,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "mtDNA-reverted L6 GLUT4myc myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596981:Myocytes [Cell]
Processing 00000000.tx.248: A, total RNA from control, mtDNA-depleted (Depleted), and mtDNA-reverted (Reverted) L6 GLUT4myc myocytes was prepared as described under "Experimental Procedures." 

Phrase: "A,"

Phrase: "total RNA from control,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "mtDNA-depleted"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(Depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(Reverted"

Phrase: ")"

Phrase: "L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.249: Syntaxin 4, SNAP23, VAMP2, TC10, and -actin mRNA levels were analyzed by RT-PCR and visualized on agarose gel. 

Phrase: "Syntaxin 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0380201:Syntaxin 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1823142:SYNTAXIN 4 [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SNAP23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420269:SNAP23 [Gene or Genome]

Phrase: "VAMP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0148340:VAMP-2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VAMP-2 [Gene or Genome]

Phrase: "TC10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425056:TC10 [Gene or Genome]

Phrase: "and -"

Phrase: "actin mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed by RT-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "visualized on agarose gel."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1706746:Agarose Gel [Research Device]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0036681:Agarose [Carbohydrate]
   770   C0234621:Visualized [Functional Concept]
   770   C1382104:Gel [Substance]
Processing 00000000.tx.250: B, in order to confirm transcript levels, syntaxin 4, SNAP23, VAMP2, and TC10 mRNA were analyzed by qRT-PCR using the specific primers indicated in Table I. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "transcript levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0441889:Levels [Qualitative Concept]
   861   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "syntaxin 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0380201:Syntaxin 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1823142:SYNTAXIN 4 [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SNAP23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420269:SNAP23 [Gene or Genome]

Phrase: "VAMP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0148340:VAMP-2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VAMP-2 [Gene or Genome]

Phrase: "and"

Phrase: "TC10 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "analyzed by qRT-PCR"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   804   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   804   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   778   C1550177:Real Time [Idea or Concept]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0040223:Time [Temporal Concept]
   748   C0237400:Real [Qualitative Concept]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0677874:pCR [Finding]
   748   C0936012:Analyzed [Research Activity]
   748   C3272377:REAL [Intellectual Product]
   748   C3541383:Time [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "indicated in Table I."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1444656:Indicated [Finding]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.251: The comparative CT method was used to analyze the data by generating relative values of the amount of target cDNA. 

Phrase: "The comparative CT method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025663:Method [Intellectual Product]
   804   C0449851:Method [Functional Concept]
   804   C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the data by generating relative values of the amount of target cDNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C1511726:Data [Idea or Concept]
   736   C3245479:data [Medical Device]
   734   C1704610:Data Value [Intellectual Product]
Processing 00000000.tx.252: The relative values were expressed in arbitrary units, where the intensity of control L6 GLUT4myc myocytes was set to 100%.  

Phrase: "The relative values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0205345:Relative Value [Qualitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "expressed in arbitrary units,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "where"

Phrase: "the intensity of control L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "set to 100%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.253: We also assessed the effect of mtDNA depletion on the insulin-stimulated phosphorylation of IRS-1 and Akt2/PKB in these cells. 

Phrase: "We also"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the effect of mtDNA depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the insulin-stimulated phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "of IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "Akt2/PKB in these cells."
Processing 00000000.tx.254: Cellular insulin treatment drastically increased phosphorylation of IRS-1 as compared with the basal level (Fig. 8). 

Phrase: "Cellular insulin treatment drastically increased phosphorylation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0031715:Phosphorylation [Molecular Function]
   738   C1158886:Phosphorylation [Molecular Function]

Phrase: "as"

Phrase: "compared with the basal level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205112:Basal [Spatial Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C1707455:Compared [Activity]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.255: However, mtDNA depletion vastly affected the expression and phosphorylation levels of IRS-1 (Fig. 8). 

Phrase: "However,"

Phrase: "mtDNA depletion vastly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   812   C0333668:Depletion [Functional Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "phosphorylation levels of IRS-1"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   774   C0202098:insulin levels [Laboratory Procedure]
   774   C0428405:insulin levels [Laboratory or Test Result]
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.256: The expression of IRS-1 measured in the depleted cells was decreased by 80% of the control level, and the insulin-stimulated phosphorylation of IRS-1 nearly disappeared. 

Phrase: "The expression of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "measured in the depleted cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0333668:Depleted [Functional Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C3282337:Cells [Cell]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "decreased by 80% of the control level,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   748   C0205216:Decreased [Quantitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2946261:Level [Pharmacologic Substance]
   748   C3274648:Control [Qualitative Concept]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "the insulin-stimulated phosphorylation of IRS-1 nearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "disappeared."
Processing 00000000.tx.257: Upon mtDNA repletion, insulin-stimulated phosphorylation of IRS-1 returned to near control. 

Phrase: "Upon mtDNA repletion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "insulin-stimulated phosphorylation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "returned to near control."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C0332156:Return to [Qualitative Concept]
           Return
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.258: In similar experiments, insulin-stimulated phosphorylation of Akt2/PKB was also drastically increased in the control and reverted cells, whereas it was nearly totally abolished by mtDNA depletion. 

Phrase: "In similar experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "insulin-stimulated phosphorylation of Akt2/PKB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "also drastically"

Phrase: "increased in the control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205217:Increased [Quantitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "reverted cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "it"

Phrase: "was"

Phrase: "nearly totally"

Phrase: "abolished by mtDNA depletion."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0333668:Depletion [Functional Concept]
   760   C0521451:Mitochondrial [Functional Concept]
Processing 00000000.tx.259: It is therefore suggested that the reduction of IRS-1 expression and insulin-stimulated phosphorylation of IRS-1 and Akt2/PKB result in impaired insulin-stimulated GLUT4 translocation and glucose uptake in mtDNA-depleted cells. 

Phrase: "It"

Phrase: "is"

Phrase: "therefore"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the reduction of IRS-1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "insulin-stimulated phosphorylation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Akt2/PKB result in impaired insulin-stimulated GLUT4 translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]

Phrase: "and"

Phrase: "glucose uptake in mtDNA-depleted cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1159527:glucose uptake [Cell Function]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.260: View larger version (64K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(64K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.261: 8. 

Phrase: "8."
Processing 00000000.tx.262: Effect of mtDNA content changes on the expression and phosphorylation of IRS-1 and Akt2/PKB. 

Phrase: "Effect of mtDNA content changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "phosphorylation of IRS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "and"

Phrase: "Akt2/PKB."
Processing 00000000.tx.263: Control, mtDNA-depleted (Depleted), and mtDNA-reverted (Reverted) L6 GLUT4myc myocytes were starved of serum for 5 h. 

Phrase: "Control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "mtDNA-depleted"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0333668:Depleted [Functional Concept]
   755 E C1550032:Unload [Idea or Concept]
   755 E C1880497:Empty [Qualitative Concept]
   755 E C1996907:Emptying [Activity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(Depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mtDNA-reverted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(Reverted"

Phrase: ")"

Phrase: "L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "were"

Phrase: "starved of serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   756   C2348531:Starve [Activity]

Phrase: "for 5 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.264: Cells were preincubated in the absence or presence of insulin (100 nM for 20 min), and total cell lysates were prepared as described under "Experimental Procedures." 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of insulin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "(100 nM for 20 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "total cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.265: Total cell lysates (50 g of protein) were subjected to 8% SDS-PAGE, and the expression (IRS-1 and Akt2/PKB) and phosphorylation (pIRS-1 and pAkt2/PKB) levels were determined by immunoblotting with specific antibodies described under "Experimental Procedures."   

Phrase: "Total cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(50 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "subjected to 8% SDS-PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C1704732:Page [Intellectual Product]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "Akt2/PKB"

Phrase: ")"

Phrase: "and"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "(pIRS-1"

Phrase: "and"

Phrase: "pAkt2/PKB"

Phrase: ")"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "with specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.266: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Reduction of oxidative enzyme activities impairs regulation of glucose and lipid metabolism in skeletal muscle and is closely associated with the development of insulin resistance in obesity and NIDDM (50, 51). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reduction of oxidative enzyme activities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C2267000:Reduction Activity [Molecular Function]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "impairs"

Phrase: "regulation of glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "lipid metabolism in skeletal muscle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0598783:Lipid Metabolism [Molecular Function]
   806   C1517898:Lipid Metabolism [Molecular Function]
   797   C0596984:metabolism muscle [Organ or Tissue Function]
   760   C0023779:Lipid [Lipid]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "closely"

Phrase: "associated with the development of insulin resistance"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0237834:Resistance [Mental Process]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1514892:Resistance [Physiologic Function]
   748   C1527148:Development [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "NIDDM"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(50,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.267: Since the bioenergetic capacity of skeletal muscle mitochondria is impaired in NIDDM and obesity (52), prolonged disturbances in the function of mitochondria may be involved in the development of insulin resistance in skeletal muscle. 

Phrase: "Since"

Phrase: "the bioenergetic capacity of skeletal muscle mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1516240:Capacity [Quantitative Concept]

Phrase: "is"

Phrase: "impaired in NIDDM"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   897   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   897   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   853   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   778   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0221099:Impaired [Functional Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1518422:Non [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "(52"

Phrase: ")"

Phrase: ","

Phrase: "prolonged disturbances in the function of mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   721   C0277785:Functional disturbance [Qualitative Concept]
   714   C2699787:Disturbance [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "involved in the development of insulin resistance"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0237834:Resistance [Mental Process]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1314939:Involved [Functional Concept]
   748   C1514892:Resistance [Physiologic Function]
   748   C1527148:Development [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.268: Accumulation of monogenic abnormalities in mtDNA (1416) and reduction of mtDNA content are also described in diabetic animals and human subjects (2123), suggesting that the decrease of mtDNA content might be a causal factor in type 2 diabetes. 

Phrase: "Accumulation of monogenic abnormalities"

Phrase: "in mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "(1416"

Phrase: ")"

Phrase: "and"

Phrase: "reduction of mtDNA content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "also"

Phrase: "described in diabetic animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003062:Animals [Animal]
   770   C0241863:DIABETIC [Finding]
   770   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "human subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0178693:human subjects [Research Activity]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(2123"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the decrease of mtDNA content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "a causal factor in type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0960756:factor A [Organic Chemical]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.269: However, there is as yet no convincing evidence indicating whether the reduction of cellular mtDNA content in peripheral tissues, such as muscle cells, causes substantial disturbances in glucose uptake and insulin signaling with the development of insulin resistance. 

Phrase: "However,"

Phrase: "there"

Phrase: "is as yet"

Phrase: "no convincing evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicating"

Phrase: "whether"

Phrase: "the reduction of cellular mtDNA content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in peripheral tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "such as muscle cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0596981:Muscle Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0026845:Muscle [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "substantial disturbances in glucose uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2699787:Disturbance [Qualitative Concept]

Phrase: "and"

Phrase: "insulin signaling with the development of insulin resistance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]
Processing 00000000.tx.270: To investigate the correlation between the alteration of mtDNA content and insulin resistance, here we used insulin-sensitive L6 myocytes stably expressing an extracellular myc epitope-tagged GLUT4 (L6 GLUT4myc) (34, 35). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the correlation between the alteration of mtDNA content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "here"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "insulin-sensitive L6 myocytes stably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596981:Myocytes [Cell]

Phrase: "expressing"

Phrase: "an extracellular myc epitope-tagged GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1420175:GLUT4 [Gene or Genome]
   804   C2982484:GLUT4 [Gene or Genome]

Phrase: "(L6 GLUT4myc"

Phrase: ")"

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.271: GLUT4 stably expressed in L6 GLUT4myc myocytes constantly recycles between the PM intracellular storage pools without differentiation or myotube formation (35, 36). 

Phrase: "GLUT4 stably"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420175:GLUT4 [Gene or Genome]
   861   C2982484:GLUT4 [Gene or Genome]

Phrase: "expressed in L6 GLUT4myc myocytes constantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596981:Myocytes [Cell]

Phrase: "recycles between the PM intracellular storage"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0007603:Plasma membrane [Cell Component]
   778   C1659466:intracellular storage [Cell Function]
   774   C0021868:Intracellular membrane [Cell Component]
   748   C0025255:Membrane [Tissue]
   748   C0032105:Plasma [Body Substance]
   748   C0175996:intracellular [Cell Component]
   748   C0178719:Intracellular [Spatial Concept]
   748   C0337174:Storage [Spatial Concept]
   748   C0596901:Membrane [Cell Component]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1698986:Storage [Functional Concept]
   748   C1706182:Membrane [Manufactured Object]
   748   C1753314:storage [Cell Component]

Phrase: "pools without differentiation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0007589:Differentiation [Cell Function]
   790   C0337051:Pool [Geographic Area]
   790   C1509144:pool [Clinical Attribute]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2349200:Pool [Functional Concept]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]

Phrase: "or"

Phrase: "myotube formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.272: Approximately 90% of GLUT4 in this cell is sequestered in intracellular endosomes in the absence of insulin stimulation (36). 

Phrase: "Approximately 90% of GLUT4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332232:Approximately [Qualitative Concept]
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   770   C1420175:GLUT4 [Gene or Genome]
   770   C2982484:GLUT4 [Gene or Genome]

Phrase: "in this cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "sequestered in intracellular endosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034850:Endosomes [Cell Component]
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C0333312:Sequestered [Functional Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of insulin stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.273: Insulin stimulates glucose uptake in this cell by inducing net translocation of GLUT4 from the intracellular storage sites to the PM (36). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "glucose uptake in this cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1159527:glucose uptake [Cell Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "by inducing net translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]

Phrase: "of GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "from the intracellular storage sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
   734   C1659466:intracellular storage [Cell Function]

Phrase: "to the PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.274: Moreover, insulin-stimulated glucose uptake is completely blocked by wortmannin and the cytoskeleton disruptors (34), and insulin-dependent stimulation of PI3K or Akt activities was observed as in primary muscle and adipocytes (34, 35). 

Phrase: "Moreover,"

Phrase: "insulin-stimulated glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "is"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked by wortmannin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0028778:Blocked [Pathologic Function]
   790   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "the cytoskeleton disruptors"

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "insulin-dependent stimulation of PI3K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "Akt activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "as in primary muscle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026845:Muscle [Tissue]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.275: The translocation of GLUT4 from intracellular storage to the plasma membrane was decreased by expression of dominant negative mutants of PI3K and Akt2/PKB (37) and was sensitive to agents that prevent actin remodeling (38, 39). 

Phrase: "The translocation of GLUT4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C2987521:Translocation [Activity]

Phrase: "from intracellular storage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1659466:intracellular storage [Cell Function]
   861   C0337174:Storage [Spatial Concept]
   861   C1698986:Storage [Functional Concept]
   861   C1753314:storage [Cell Component]

Phrase: "to the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "decreased by expression of dominant negative mutants of PI3K"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   775   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   759   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
           Dominant Negative
   748 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0205160:Negative [Qualitative Concept]
   738   C0205216:Decreased [Quantitative Concept]
   738   C0392756:Decreased [Qualitative Concept]
   738   C0442797:decreased [Qualitative Concept]
   738   C0596988:mutants [Cell or Molecular Dysfunction]
   738   C1513916:Negative [Finding]
   738   C1527180:Dominant [Functional Concept]
   738   C2348046:Phosphatidylinositol [Lipid]
   738   C2825415:Negative [Conceptual Entity]
   738   C2825491:Negative [Qualitative Concept]
   704 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "Akt2/PKB"

Phrase: "(37"

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "sensitive to agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332324:Sensitive to [Functional Concept]
           Sensitive
   790   C1550474:sensitive [Idea or Concept]

Phrase: "that"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "actin remodeling"

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.276: Thus, L6 GLUT4myc myocytes represent an appropriate cellular model to study how insulin stimulates glucose utilization. 

Phrase: "Thus,"

Phrase: "L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an appropriate cellular model to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Model [Intellectual Product]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "how insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "glucose utilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]
Processing 00000000.tx.277: The cellular treatment with low dose EtBr specifically inhibits transcription and replication of circular DNA by deleting RNA primers required for the initiation of replication (2426) and has been a useful tool for the study of cellular responses affected by changes in mtDNA contents (2830). 

Phrase: "The cellular treatment with low dose EtBr specifically"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   784   C1708745:Low-Dose Treatment [Research Activity]
   742   C0039798:treatment [Functional Concept]
   742   C0087111:Treatment [Therapeutic or Preventive Procedure]
   742   C1522326:Treatment [Functional Concept]
   742   C1533734:Treatment [Therapeutic or Preventive Procedure]
   742   C1705169:Treatment [Conceptual Entity]
   742   C3538994:TREATMENT [Research Activity]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "replication of circular DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0598312:DNA Replication [Genetic Function]
           Replication
   819   C2984261:DNA replication [Functional Concept]
   770   C1883725:replication [Qualitative Concept]

Phrase: "by deleting RNA primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0073429:RNA primers [Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "required for the initiation of replication"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1155650:Replication Initiation [Genetic Function]
   753   C0589507:Initiation [Mental Process]
   753   C0598312:Replication [Genetic Function]
   753   C1158830:Initiation [Genetic Function]
   753   C1514873:Required [Functional Concept]
   753   C1704686:Initiation [Functional Concept]
   753   C1883725:replication [Qualitative Concept]

Phrase: "(2426"

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "a useful tool for the study of cellular responses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0336791:Tool [Manufactured Object]
   742   C2827396:Tool [Manufactured Object]
   726   C0871532:tool use [Finding]

Phrase: "affected by changes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0392747:changes [Functional Concept]
   790   C0392760:Affected [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in mtDNA contents"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0456205:Contents [Conceptual Entity]
   827   C1552853:contents [Idea or Concept]
   793 E C0423896:Content [Mental Process]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "(2830"

Phrase: ")."
Processing 00000000.tx.278: In the present study, we generated a set of L6 GLUT4myc cell lines containing partially depleted mtDNA (95% of control level) by EtBr treatment, followed by single cell cloning. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a set of L6 GLUT4myc cell lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0036849:Set [Mental Process]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "partially"

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "mtDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "(95% of control level"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0243148:control [Qualitative Concept]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2946261:Level [Pharmacologic Substance]
   770   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "by EtBr treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]

Phrase: "followed by single cell cloning."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0009013:cell cloning [Cell]
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0007634:Cell [Cell]
   760   C0009015:Cloning [Research Activity]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.279: This mtDNA depletion and repletion protocol has been successfully applied to C2C12 cells (2830) and HeLa cells (53), although the concentration and duration of EtBr treatment in each cell type having different susceptibility to EtBr were modified. 

Phrase: "This mtDNA depletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   827   C0333668:Depletion [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "repletion protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "successfully"

Phrase: "applied to C2C12 cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0185125:Applied [Health Care Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1632850:Apply [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1879355:Apply [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(2830"

Phrase: ")"

Phrase: "and"

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(53"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "duration of EtBr treatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0444921:Duration of treatment [Temporal Concept]
           duration treatment
   760   C0449238:Duration [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "in each cell type"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007634:Cell Type [Cell]
           Cell
  1000   C0449475:cell type [Intellectual Product]
   861   C0332307:Type [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1547052:*Type [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "having"

Phrase: "different susceptibility to EtBr"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "were"

Phrase: "modified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]
Processing 00000000.tx.280: Partially mtDNA-depleted L6 GLUT4myc myocytes exhibited normal nuclear DNA content, disruption of mitochondria m, and significantly reduced cellular ATP content (Figs. 1 and 2). 

Phrase: "Partially mtDNA-depleted L6 GLUT4myc myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0596981:Myocytes [Cell]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "normal nuclear DNA content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "disruption of mitochondria m,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "and"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "cellular ATP content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "(Figs. 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.281: These changes were reversed to nearly normal levels in the reverted cells, whose mtDNA content recovered upon retrieving EtBr from the culture medium (Figs. 1 and 2). 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "to nearly normal levels in the reverted cells,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "whose mtDNA content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "recovered upon retrieving EtBr"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   760   C0006222:Bromide [Inorganic Chemical]
   760   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   760   C0521108:recovered [Qualitative Concept]
   726 E C2004454:recover [Organism Function]

Phrase: "from the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "(Figs. 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.282: Together, these findings indicate that the depletion and repletion protocol applied here to L6 GLUT4myc myocytes effectively altered mtDNA content without causing general cell damage and is appropriate for studying the effect of mtDNA alteration on glucose utilization and insulin sensitivity. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333668:Depletion [Functional Concept]

Phrase: "and"

Phrase: "repletion protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "here to L6 GLUT4myc myocytes effectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596981:Myocytes [Cell]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "mtDNA content without causing general cell damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "is"

Phrase: "appropriate for studying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1548787:Appropriate [Qualitative Concept]
   718 E C0814634:appropriateness [Qualitative Concept]

Phrase: "the effect of mtDNA alteration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "insulin sensitivity."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.283: It is noteworthy that the depletion of mtDNA significantly reduced glucose uptake in basal and insulin-stimulated L6 GLUT4myc cells, whereas the repletion of mtDNA corrected these changes to nearly control levels (Fig. 4). 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "the depletion of mtDNA significantly reduced glucose uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   742   C0333668:Depletion [Functional Concept]

Phrase: "in basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated L6 GLUT4myc cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   881   C0030281:Insulin Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "the repletion of mtDNA"

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "these changes to nearly control levels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.284: Both 3OMG uptake and 2DG accumulation assays revealed a similar reduction in glucose uptake, validating the 2DG accumulation as a genuine transport assay free of ATP depletion artifacts. 

Phrase: "Both 3OMG uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]
   756   C0047666:3-O-Methylglucose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "2DG accumulation assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a similar reduction in glucose uptake,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "validating"

Phrase: "the 2DG accumulation as a genuine transport"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "free of ATP depletion artifacts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
Processing 00000000.tx.285: In previous studies, Antonetti et al. 

Phrase: "In previous studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "Antonetti et al."
Processing 00000000.tx.286: (22) found that skeletal muscle from type 1 and type 2 diabetic patients contains relatively less mtDNA than normal, and Lee et al. 

Phrase: "(22"

Phrase: ")"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that skeletal muscle from type 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0242692:Muscle, Skeletal [Tissue]
   790   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   753   C0026845:Muscle [Tissue]
   753   C0037253:skeletal [Body System]
   753   C0521324:Skeletal [Spatial Concept]

Phrase: "and"

Phrase: "type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "relatively less mtDNA than normal,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1819717:mitochondrial DNA [Cell Component]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "Lee et al."
Processing 00000000.tx.287: (23) also reported that decreased peripheral mtDNA content occurs before the onset of diabetes. 

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that decreased peripheral mtDNA content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]

Phrase: "occurs before the onset of diabetes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.288: More recently, it has been demonstrated that basal and insulin-stimulated glucose uptake was significantly reduced in the insulin-insensitive SK-Hep1 hepatocyte upon mtDNA depletion by EtBr treatment (46). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced in the insulin-insensitive SK-Hep1 hepatocyte"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0227525:Hepatocyte [Cell]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   735   C1864570:Insulin insensitivity [Finding]

Phrase: "upon mtDNA depletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   827   C0333668:Depletion [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "by EtBr treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.289: Our demonstration that basal glucose uptake in L6 GLUT4myc myocytes was modulated by the depletion and repletion of mtDNA (Fig. 4) is consistent with these findings and further supports the possibility that mtDNA-depleted myocytes develop severe insulin resistance. 

Phrase: "Our demonstration"

Phrase: "that basal glucose uptake in L6 GLUT4myc myocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1159527:glucose uptake [Cell Function]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "modulated by the depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333668:Depletion [Functional Concept]
   770   C0443264:Modulated [Spatial Concept]

Phrase: "and"

Phrase: "repletion of mtDNA"

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "is"

Phrase: "consistent with these findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the possibility"

Phrase: "that mtDNA-depleted myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596981:Myocytes [Cell]

Phrase: "develop"

Phrase: "severe insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.290: Although many of the acute effects of insulin on glucose transport are mediated by the recruitment of GLUT4 to the PM, decreased expression of GLUT4 can cause insulin resistance (54), and increased expression of GLUT4 promotes insulin-stimulated glucose uptake (55). 

Phrase: "Although"

Phrase: "many of the acute effects of insulin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205178:acute [Temporal Concept]
   748   C0439064:Many [Quantitative Concept]
   748   C0747726:many [Conceptual Entity]
   748   C1280500:effects [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "are"

Phrase: "mediated by the recruitment of GLUT4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1420175:GLUT4 [Gene or Genome]
   753   C2949735:Recruitment [Activity]
   753   C2982484:GLUT4 [Gene or Genome]

Phrase: "to the PM,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "decreased expression of GLUT4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(54"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "increased expression of GLUT4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "insulin-stimulated glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.291: In L6 GLUT4myc myocytes stably expressing GLUT4, the total cellular GLUT4 amount was not affected by the changes of mtDNA content (Fig. 5A), whereas GLUT4 in the PM was clearly decreased by mtDNA depletion (Fig. 5A). 

Phrase: "In L6 GLUT4myc myocytes stably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596981:Myocytes [Cell]

Phrase: "expressing"

Phrase: "GLUT4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "the total cellular GLUT4 amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the changes of mtDNA content"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1819717:mitochondrial DNA [Cell Component]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0392747:changes [Functional Concept]
   744   C0392760:Affected [Functional Concept]
   744   C0423896:Content [Mental Process]
   744   C0443172:changes [Quantitative Concept]
   744   C0456205:Content [Conceptual Entity]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C1314939:Affected [Functional Concept]
   711 E C0001721:Affect [Mental Process]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "GLUT4 in the PM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1420175:GLUT4 [Gene or Genome]
   760   C2982484:GLUT4 [Gene or Genome]

Phrase: "was"

Phrase: "clearly"

Phrase: "decreased by mtDNA depletion"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0333668:Depletion [Functional Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.292: Since basal and insulin-stimulated glucose uptake in muscle and adipose cells largely correlates with the absolute amount of GLUT4 in the PM, the reduced basal 2DG uptake observed in the depleted cells most likely results from the reduction of PM GLUT4 level. 

Phrase: "Since"

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated glucose uptake in muscle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1159527:glucose uptake [Cell Function]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "adipose cells largely"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0206131:adipose cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]

Phrase: "correlates with the absolute amount of GLUT4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205344:Absolute [Qualitative Concept]
   748   C1265611:Amount [Quantitative Concept]
   748   C1420175:GLUT4 [Gene or Genome]
   748   C2982484:GLUT4 [Gene or Genome]

Phrase: "in the PM,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "the reduced basal 2DG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0243144:Uptake [Physiologic Function]
   804   C0347980:% uptake [Quantitative Concept]

Phrase: "observed in the depleted cells most likely results"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   744   C0007634:Cells [Cell]
   744   C0332148:Likely [Qualitative Concept]
   744   C0333668:Depleted [Functional Concept]
   744   C0750492:Likely [Idea or Concept]
   744   C1441672:Observed [Functional Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   711   C2825142:Result [Finding]

Phrase: "from the reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of PM GLUT4 level."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.293: How at the molecular and cellular levels mtDNA depletion causes a reduction in PM GLUT4 content and insulin resistance is an important question yet to be answered. 

Phrase: "How at the molecular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "cellular levels mtDNA depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   804   C0333668:Depletion [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a reduction in PM GLUT4 content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "an important question yet to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1522634:Question [Intellectual Product]

Phrase: "be"

Phrase: "answered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706817:Answer [Intellectual Product]
Processing 00000000.tx.294: Our demonstration that the mtDNA depletion causes a drastic reduction in the expression of IRS-1 and its insulin-stimulated phosphorylation (Figs. 6 and 8) clearly suggests that IRS-1 plays a key role in this process. 

Phrase: "Our demonstration"

Phrase: "that"

Phrase: "the mtDNA depletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   827   C0333668:Depletion [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a drastic reduction in the expression of IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0301630:Reduction [Natural Phenomenon or Process]
   738   C0392756:Reduction [Qualitative Concept]
   738   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its insulin-stimulated phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Figs. 6"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "8"

Phrase: ")"

Phrase: "clearly"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a key role in this process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.295: The effect of mtDNA depletion on IRS-1 expression is quite selective. 

Phrase: "The effect of mtDNA depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on IRS-1 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0597360:receptor expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "is"

Phrase: "quite selective."
Processing 00000000.tx.296: The mtDNA depletion did not affect the expression of other insulin signaling intermediates such as insulin receptor, PI3K, PDK-1, and Akt2/PKB (Fig. 6). 

Phrase: "The mtDNA depletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   827   C0333668:Depletion [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the expression of other insulin signaling intermediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "such as insulin receptor,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PDK-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Akt2/PKB"

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.297: Several key proteins essential to vesicle trafficking/exocytosis, including syntaxin 4, SNAP23, VAMP2, and TC10 were also not affected by the mtDNA depletion (Fig. 7), indicating that the regulation occurs within the insulin signal transduction prior to GLUT4 vesicle trafficking. 

Phrase: "Several key proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "essential to vesicle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205224:Essential [Qualitative Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "/exocytosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "syntaxin 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0380201:Syntaxin 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1823142:SYNTAXIN 4 [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SNAP23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420269:SNAP23 [Gene or Genome]

Phrase: "VAMP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0148340:VAMP-2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VAMP-2 [Gene or Genome]

Phrase: "and"

Phrase: "TC10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425056:TC10 [Gene or Genome]

Phrase: "were"

Phrase: "also"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the mtDNA depletion"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   790   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1819717:mitochondrial DNA [Cell Component]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0333668:Depletion [Functional Concept]
   753   C0392760:Affected [Functional Concept]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   719 E C0001721:Affect [Mental Process]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "occurs within the insulin signal transduction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0037083:Signal Transduction [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1160185:transduction [Organism Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1709305:Occur [Activity]
   753   C1710082:Signal [Phenomenon or Process]
   753   C2745955:OCCUR [Temporal Concept]

Phrase: "prior to GLUT4 vesicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0333262:Vesicle [Acquired Abnormality]
   861   C1622418:vesicle [Cell Component]
   789 E C0205378:Vesicular [Qualitative Concept]

Phrase: "trafficking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]
Processing 00000000.tx.298: Alterations in mtDNA quantity and quality have been known to induce mitochondria-to-nucleus stress signaling and change the expression level of various nuclear DNA-encoded genes in vertebrate cells (2831). 

Phrase: "Alterations in mtDNA quantity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   781   C0596611:DNA Alteration [Genetic Function]
   781   C2267112:DNA Alteration [Cell Function]
   726   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "quality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332306:Quality [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "mitochondria-to-nucleus stress signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the expression level of various nuclear DNA-encoded genes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C3244092:expression level [Idea or Concept]
   745   C0017262:Gene Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "in vertebrate cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(2831"

Phrase: ")."
Processing 00000000.tx.299: Insulin regulates GLUT4 translocation largely through the activation of IRS-1 via tyrosine phosphorylation with subsequent activation/phosphorylation of its downstream effectors, viz. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "GLUT4 translocation largely through the activation of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0040715:Translocation [Cell or Molecular Dysfunction]
   738   C2987521:Translocation [Activity]

Phrase: "via tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "with subsequent activation/phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "of its downstream effectors,"

Phrase: "viz."
Processing 00000000.tx.300: PI3K, PDK-1, protein kinase C /, and Akt2/PKB (56, 57). 

Phrase: "PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PDK-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase C /,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Akt2/PKB"

Phrase: "(56,"

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.301: Although we find that insulin-stimulated Akt2/PKB phosphorylation is also reduced after mtDNA depletion (Fig. 8), it is possible that the mtDNA depletion reduces tyrosine phosphorylation of IRS-1 selectively, and the reduced insulin-stimulated Akt2/PKB phosphorylation observed in mtDNA-depleted cells is mostly due to the reduced IRS-1 phosphorylation. 

Phrase: "Although"

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that insulin-stimulated Akt2/PKB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "also"

Phrase: "reduced after mtDNA depletion"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   806   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1819717:mitochondrial DNA [Cell Component]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0333668:Depletion [Functional Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0521451:Mitochondrial [Functional Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the mtDNA depletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   827   C0333668:Depletion [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "reduces"

Phrase: "tyrosine phosphorylation of IRS-1 selectively,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1519726:Tyrosine Phosphorylation [Molecular Function]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "the reduced insulin-stimulated Akt2/PKB phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]

Phrase: "observed in mtDNA-depleted cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1819717:mitochondrial DNA [Cell Component]
   753   C0007634:Cells [Cell]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0333668:Depleted [Functional Concept]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1441672:Observed [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "mostly due to the reduced IRS-1 phosphorylation."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   806   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   760   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   760   C0678226:Due to [Functional Concept]
           due
   760   C1334133:INSULIN RECEPTOR [Gene or Genome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0392756:Reduced [Qualitative Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0750554:mostly [Idea or Concept]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1710236:Substrate [Manufactured Object]
   739   C3146286:Due [Idea or Concept]
Processing 00000000.tx.302: IRS-1 is suggested as one of the critical mediators for the insulin-stimulated GLUT4 translocation and glucose uptake in skeletal muscle. 

Phrase: "IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "suggested as one of the critical mediators"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   748   C0205447:One [Quantitative Concept]
   748   C1511545:Critical [Qualitative Concept]
   714 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C1705535:Suggest [Idea or Concept]

Phrase: "for the insulin-stimulated GLUT4 translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040715:Translocation [Cell or Molecular Dysfunction]
   812   C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "glucose uptake in skeletal muscle."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1159527:glucose uptake [Cell Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.303: The reduced expression of IRS-1 and insulin-stimulated tyrosine phosphorylation of IRS-1 in skeletal muscle has been observed in both type 2 diabetes (58, 59) and animal models (6062). 

Phrase: "The reduced expression of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "insulin-stimulated tyrosine phosphorylation of IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1519726:Tyrosine Phosphorylation [Molecular Function]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "observed in both type 2 diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0011860:Type 2 Diabetes [Disease or Syndrome]
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "(58,"

Phrase: "59"

Phrase: ")"

Phrase: "and"

Phrase: "animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "(6062"

Phrase: ")."
Processing 00000000.tx.304: Studies using IRS-1 or -2 knock-out mice also suggested that IRS-1 plays a major role in insulin-stimulated glucose transport, and IRS-2 may only partially compensate for defects in IRS-1 signaling (63, 64). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "IRS-1 or -2 knock-out mice also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   821   C0206745:Knock-out Mice [Mammal]
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a major role in insulin-stimulated glucose transport,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "IRS-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0381451:Insulin Receptor Substrate-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334141:INSULIN RECEPTOR SUBSTRATE 2 [Gene or Genome]
  1000   C1334191:Insulin Receptor Substrate 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "only partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "compensate for defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205432:compensate [Qualitative Concept]
   790   C0243067:defects [Functional Concept]
   756 E C1457869:Defect [Functional Concept]
   756 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in IRS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "(63,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.305: How does mtDNA depletion decrease the amount and phosphorylation of IRS-1 at the molecular level? 

Phrase: "How"

Phrase: "does"

Phrase: "mtDNA depletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0342782:Mitochondrial DNA depletion [Disease or Syndrome]
   827   C0333668:Depletion [Functional Concept]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "phosphorylation of IRS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "at the molecular level?"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.306: It is tempting to suggest a role for protein kinase C and ceramides, two key intermediates of lipotoxicity produced by decreased fatty acid oxidation associated with mitochondrial dysfunction, in this process. 

Phrase: "It"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role for protein kinase C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "ceramides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramides [Biologically Active Substance,Lipid]

Phrase: "two key intermediates of lipotoxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205103:Intermediate [Spatial Concept]
   726   C1550465:intermediate [Idea or Concept]
   726   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "produced by decreased fatty acid oxidation"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1158366:fatty acid oxidation [Molecular Function]
   790   C0015684:Fatty acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0030011:Oxidation [Molecular Function]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "associated with mitochondrial dysfunction,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0026237:Mitochondrial [Cell Component]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0521451:Mitochondrial [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "in this process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.307: Free fatty acids and cellular stress can result in increased serine phosphorylation and reduced tyrosine phosphorylation of IRS-1, thereby attenuating insulin signaling and causing insulin resistance in type 2 diabetes (65, 66). 

Phrase: "Free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "cellular stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516373:Cellular Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "can"

Phrase: "result in increased serine phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "and"

Phrase: "reduced tyrosine phosphorylation of IRS-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1519726:Tyrosine Phosphorylation [Molecular Function]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "thereby"

Phrase: "attenuating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0599946:Attenuate [Activity]

Phrase: "insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "causing insulin resistance in type 2 diabetes"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   840   C0342335:Insulin resistance in diabetes [Disease or Syndrome]
           diabetes insulin resistance
   781 E C0854110:Insulin resistant diabetes [Disease or Syndrome]
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   774   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ")."
Processing 00000000.tx.308: Protein kinase C phosphorylates IRS-1 at serine 1101, blocking IRS-1 tyrosine phosphorylation and downstream activation of the Akt2/PKB (67). 

Phrase: "Protein kinase C"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylates"

Phrase: "IRS-1 at serine 1101,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   853   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   778   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   778   C1334133:INSULIN RECEPTOR [Gene or Genome]
   774   C0074377:serine receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1710236:Substrate [Manufactured Object]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "IRS-1 tyrosine phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1519726:Tyrosine Phosphorylation [Molecular Function]
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]
   734   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "and"

Phrase: "downstream activation of the Akt2/PKB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.309: Undoubtedly, more work is needed to determine the molecular events underlying the modulation of IRS-1 expression and its insulin-stimulated phosphorylation by cellular mtDNA content change. 

Phrase: "Undoubtedly,"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the molecular events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "underlying"

Phrase: "the modulation of IRS-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "its insulin-stimulated phosphorylation by cellular mtDNA content change."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.310: In conclusion, our data clearly show that the depletion of mtDNA is directly correlated with a drastic reduction in basal and insulin-stimulated glucose uptake and GLUT4 translocation in L6 GLUT4myc myocytes. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our data clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the depletion of mtDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   926   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   760   C0333668:Depletion [Functional Concept]

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "correlated with a drastic reduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C1707520:Correlated [Qualitative Concept]

Phrase: "in basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "GLUT4 translocation in L6 GLUT4myc myocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040715:Translocation [Cell or Molecular Dysfunction]
   753   C2987521:Translocation [Activity]
Processing 00000000.tx.311: It is also clear in our data that the depletion of mtDNA causes a selective and reversible reduction in IRS-1 mRNA and protein levels and in insulin-stimulated IRS-1 and Akt2/PKB phosphorylation. 

Phrase: "It"

Phrase: "is"

Phrase: "also"

Phrase: "clear in our data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511726:Data [Idea or Concept]
   770   C2963144:Clear [Qualitative Concept]
   770   C3245479:data [Medical Device]

Phrase: "that"

Phrase: "the depletion of mtDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   926   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   760   C0333668:Depletion [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a selective"

Phrase: "and"

Phrase: "reversible reduction in IRS-1 mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and in insulin-stimulated IRS-1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   822   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   822   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   767   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   767   C1334133:INSULIN RECEPTOR [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1515981:And [Idea or Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1710236:Substrate [Manufactured Object]
   744   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "Akt2/PKB phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.312: We suggest that depletion of mtDNA causes insulin resistance in L6 GLUT4myc myocytes primarily by reducing the mRNA and protein expression and the insulin-stimulated phosphorylation of IRS-1, a key intermediate of the insulin signal pathway leading to insulin-stimulated GLUT4 recruitment to the PM.  

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that depletion of mtDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   926   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   760   C0333668:Depletion [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "insulin resistance in L6 GLUT4myc myocytes primarily"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "by reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the insulin-stimulated phosphorylation of IRS-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "a key"

Phrase: "intermediate of the insulin signal pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205103:Intermediate [Spatial Concept]
   753   C1550465:intermediate [Idea or Concept]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "leading to insulin-stimulated GLUT4 recruitment"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332152:Leading [Temporal Concept]
   753   C1420175:GLUT4 [Gene or Genome]
   753   C1522538:Leading [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2949735:Recruitment [Activity]
   753   C2982484:GLUT4 [Gene or Genome]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to the PM."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.313: FOOTNOTES  * This study was supported by Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea, Grants 02-PJ1-PG1-CH04-0001 and 00-PJ3-PG6-GN07-0001 and the American Diabetes Association and Buffalo Veterans Affairs Medical Center Medical Research Services. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by Korea Health 21 R&D Project,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0018684:Health [Idea or Concept]
   744   C0022771:Korea [Geographic Area]
   744   C0333668:Depleted [Functional Concept]
   744   C1521721:Supported [Conceptual Entity]
   744   C1709701:Project [Conceptual Entity]
   711 E C0183683:Support [Medical Device]

Phrase: "Ministry of Health"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0018684:Health [Idea or Concept]
   727 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "Welfare,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037440:welfare [Self-help or Relief Organization]

Phrase: "Republic of Korea,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0022773:Republic of Korea [Geographic Area]
   827   C0022771:Korea [Geographic Area]
   755 E C1556095:Korean [Population Group]

Phrase: "Grants 02-PJ1-PG1-CH04-0001"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0018173:Grants [Quantitative Concept]
   766 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "00-PJ3-PG6-GN07-0001"

Phrase: "and"

Phrase: "the American Diabetes Association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Buffalo Veterans Affairs Medical Center Medical Research Services."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   850   C0587569:medical services [Health Care Activity]
   834 E C0199168:Medical service [Health Care Activity]
   834 E C1546531:Medical Service [Health Care Related Organization]
   793   C0557854:Services [Occupational Activity]
   760 E C2825316:Service [Manufactured Object]
   760 E C3245478:service [Idea or Concept]
Processing 00000000.tx.314: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.315: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.316: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.317: To whom correspondence should be addressed: Dept. of Biochemistry, College of Medicine, Dongguk University, Kyungju 780-714, Korea. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0557806:College [Manufactured Object]

Phrase: "Dongguk University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Kyungju 780-714,"

Phrase: "Korea."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]
Processing 00000000.tx.318: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.319: 82-54-770-2409; 

Phrase: "82-54-770-2409"

Phrase: ";"
Processing 00000000.tx.320: Fax: 82-54-770-2447; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "82-54-770-2447"

Phrase: ";"
Processing 00000000.tx.321: E-mail: wanlee{at}mail.dongguk.ac.kr . 1 The abbreviations used are: NIDDM, non-insulin-dependent diabetes mellitus; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "wanlee{at}mail.dongguk.ac.kr . 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0022773:KR [Geographic Area]
   795   C0024492:Mail [Manufactured Object]
   795   C1412573:AC [Gene or Genome]
   795   C1538057:MAIL [Gene or Genome]
   795   C1547565:Mail [Idea or Concept]
   795   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   795   C3539770:AC [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "NIDDM,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.322: mtDNA, mitochondrial DNA; 

Phrase: "mtDNA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "mitochondrial DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: ";"
Processing 00000000.tx.323: EtBr, ethidium bromide; 

Phrase: "EtBr,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "ethidium bromide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.324: PM, plasma membrane; 

Phrase: "PM,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.325: IRS, insulin receptor substrate; 

Phrase: "IRS,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C1710236:Substrate [Manufactured Object]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin receptor substrate"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C1710236:Substrate [Manufactured Object]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.326: PI3K, phosphatidylinositol 3-kinase; 

Phrase: "PI3K,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphatidylinositol 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.327: PKB, protein kinase B; 

Phrase: "PKB,"

Phrase: "protein kinase B"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0164786:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0285558:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.328: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0036082:Saline [Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.329: RT, reverse transcriptase; 

Phrase: "RT,"

Phrase: "reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1555029:Reverse [Idea or Concept]
   861   C2257077:transcriptase [Genetic Function]

Phrase: ";"
Processing 00000000.tx.330: qRT-PCR, quantitative real time RT-PCR; 

Phrase: "qRT-PCR,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   911   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   888   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: "quantitative real time RT-PCR"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   911   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   888   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.331: 2DG, 2-deoxyglucose; 

Phrase: "2DG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]
           Deoxyglucose

Phrase: "2-deoxyglucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]
           Deoxyglucose

Phrase: ";"
Processing 00000000.tx.332: 3OMG, 3-O-methylglucose; 

Phrase: "3OMG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047666:3-O-Methylglucose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "3-O-methylglucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047666:3-O-Methylglucose [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.333: COX I, II, III, and IV, cytochrome oxidase subunits I, II, III, and IV, respectively; 

Phrase: "COX I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "II,"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "IV,"

Phrase: "cytochrome oxidase subunits I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "II,"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "IV,"

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.334: PDK-1, 3-phosphoinositide-dependent protein kinase-1.  

Phrase: "PDK-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "3-phosphoinositide-dependent protein kinase-1."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C0541150:3-Phosphoinositide Dependent Protein Kinase-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335204:3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 [Gene or Genome]
   947   C0538677:3-phosphoinositide-dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0089793:Phosphoinositide Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031621:phosphoinositide [Biologically Active Substance,Lipid]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439086:<3 [Quantitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C2827736:3+ [Quantitative Concept]
   799   C2981702:3+ [Classification]
   799   C3244310:dependent [Functional Concept]
Processing 00000000.tx.335: ACKNOWLEDGMENTS  We are grateful to Dr. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Dr."
Processing 00000000.tx.336: Amira Klip (the Hospital for Sick Children, Toronto, Ontario, Canada) for kindly providing L6 GLUT4myc myocytes. 

Phrase: "Amira Klip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1426024:KLIP [Gene or Genome]

Phrase: "("

Phrase: "the Hospital for Sick Children,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0020017:Children's hospital [Health Care Related Organization]
   760   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   760   C1510665:Hospital [Qualitative Concept]

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "for kindly"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "L6 GLUT4myc myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596981:Myocytes [Cell]
Processing 00000000.tx.337: We are also grateful to Dr. 

Phrase: "We"

Phrase: "are"

Phrase: "also grateful to Dr."
Processing 00000000.tx.338: Paul J. 

Phrase: "Paul J."
Processing 00000000.tx.339: Benette (Veterans Affairs Medical Center, Buffalo, NY) for critical reading of the manuscript.  

Phrase: "Benette"

Phrase: "(Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1549054:Veterans Affairs [Organization]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0042610:Veterans [Population Group]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   779 E C3245459:veteran [Intellectual Product]

Phrase: "Buffalo,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006352:Buffalo [Mammal]
  1000   C0324533:BUFFALO [Mammal]
  1000   C1739095:Buffalo [Mammal]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "for critical reading"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034754:Reading [Daily or Recreational Activity]
   861   C1705179:Reading [Finding]

Phrase: "of the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.340: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Gould, G. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Gould,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.341: W., and Holman, G. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Holman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.342: D. 

Phrase: "D."
Processing 00000000.tx.343: (1993) Biochem. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.344: J. 

Phrase: "J."
Processing 00000000.tx.345: 295, 329341[Medline] [OrderarticleviaInfotrieve] Mueckler, M. 

Phrase: "295,"

Phrase: "329341"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mueckler,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.346: (1994) Eur. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.347: J. 

Phrase: "J."
Processing 00000000.tx.348: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.349: 219, 713725[Abstract] Bryant, N. 

Phrase: "219,"

Phrase: "713725"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bryant,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.350: J., Govers, R., and James, D. 

Phrase: "J.,"

Phrase: "Govers,"

Phrase: "R.,"

Phrase: "and"

Phrase: "James,"

Phrase: "D."
Processing 00000000.tx.351: E. 

Phrase: "E."
Processing 00000000.tx.352: (2002) Nat. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.353: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.354: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.355: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.356: Biol. 

Phrase: "Biol."
Processing 00000000.tx.357: 3, 267277[CrossRef][Medline] [OrderarticleviaInfotrieve] Jhun, B. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "267277"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jhun,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.358: H., Rampal, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rampal,"

Phrase: "A."
Processing 00000000.tx.359: L., Liu, H., Lachaal, M., and Jung, C. 

Phrase: "L., Liu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lachaal,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Jung,"

Phrase: "C."
Processing 00000000.tx.360: Y. 

Phrase: "Y."
Processing 00000000.tx.361: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.362: Biol. 

Phrase: "Biol."
Processing 00000000.tx.363: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.364: 267, 1771017715[Abstract/Free FullText] Malide, D., Dwyer, N. 

Phrase: "267,"

Phrase: "1771017715"

Phrase: "[Abstract/Free FullText"

Phrase: "] Malide,"

Phrase: "D.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "Dwyer,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.365: K., Blanchette-Mackie, E. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Blanchette-Mackie,"

Phrase: "E."
Processing 00000000.tx.366: J., and Cushman, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Cushman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.367: W. 

Phrase: "W."
Processing 00000000.tx.368: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.369: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.370: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.371: 45, 10831096[Abstract/Free FullText] Cushman, S. 

Phrase: "45,"

Phrase: "10831096"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cushman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.372: W., and Wardzala, L. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Wardzala,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.373: J. 

Phrase: "J."
Processing 00000000.tx.374: (1980) J. 

Phrase: "(1980"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.375: Biol. 

Phrase: "Biol."
Processing 00000000.tx.376: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.377: 255, 47584762[Free FullText] Suzuki, K., and Kono, T. 

Phrase: "255,"

Phrase: "47584762"

Phrase: "[Free FullText"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kono,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.378: (1980) Proc. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.379: Natl. 

Phrase: "Natl."
Processing 00000000.tx.380: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.381: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.382: U. 

Phrase: "U."
Processing 00000000.tx.383: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.384: A. 

Phrase: "A."
Processing 00000000.tx.385: 77, 25422545[Abstract] Lee, W., Ryu, J., Souto, R. 

Phrase: "77,"

Phrase: "25422545"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lee,"

Phrase: "W.,"

Phrase: "Ryu,"

Phrase: "J.,"

Phrase: "Souto,"

Phrase: "R."
Processing 00000000.tx.386: P., Pilch, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Pilch,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.387: F., and Jung, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Jung,"

Phrase: "C."
Processing 00000000.tx.388: Y. 

Phrase: "Y."
Processing 00000000.tx.389: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.390: Biol. 

Phrase: "Biol."
Processing 00000000.tx.391: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.392: 274, 3775537762[Abstract/Free FullText] Lee, W., Ryu, J., Spangler, R. 

Phrase: "274,"

Phrase: "3775537762"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "W.,"

Phrase: "Ryu,"

Phrase: "J.,"

Phrase: "Spangler,"

Phrase: "R."
Processing 00000000.tx.393: A., and Jung, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Jung,"

Phrase: "C."
Processing 00000000.tx.394: Y. 

Phrase: "Y."
Processing 00000000.tx.395: (2000) Biochemistry 39, 93589366[CrossRef][Medline] [OrderarticleviaInfotrieve] Watson, R. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochemistry 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "93589366"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "R."
Processing 00000000.tx.396: T., and Pessin, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Pessin,"

Phrase: "J."
Processing 00000000.tx.397: E. 

Phrase: "E."
Processing 00000000.tx.398: (2001) Recent Prog. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Recent Prog."
Processing 00000000.tx.399: Horm. 

Phrase: "Horm."
Processing 00000000.tx.400: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.401: 56, 175193[Abstract/Free FullText] Froguel, P., and Velho, G. 

Phrase: "56,"

Phrase: "175193"

Phrase: "[Abstract/Free FullText"

Phrase: "] Froguel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Velho,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.402: (2001) Recent Prog. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Recent Prog."
Processing 00000000.tx.403: Horm. 

Phrase: "Horm."
Processing 00000000.tx.404: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.405: 56, 91105[Abstract/Free FullText] Gerbitz, K. 

Phrase: "56,"

Phrase: "91105"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gerbitz,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.406: D., Gempel, K., and Brdiczka, D. 

Phrase: "D.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "Gempel,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Brdiczka,"

Phrase: "D."
Processing 00000000.tx.407: (1996) Diabetes 45, 113126[Abstract] Anderson, S., Bankier, A. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Diabetes 45,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "113126"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Anderson,"

Phrase: "S."

Phrase: ","

Phrase: "Bankier,"

Phrase: "A."
Processing 00000000.tx.408: T., Barrell, B. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Barrell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.409: G., de Bruijn, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "de Bruijn,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.410: H., Coulson, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Coulson,"

Phrase: "A."
Processing 00000000.tx.411: R., Drouin, J., Eperon, I. 

Phrase: "R.,"

Phrase: "Drouin,"

Phrase: "J.,"

Phrase: "Eperon,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.412: C., Nierlich, D. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Nierlich,"

Phrase: "D."
Processing 00000000.tx.413: P., Roe, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Roe,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.414: A., Sanger, F., Schreier, P. 

Phrase: "A.,"

Phrase: "Sanger,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Schreier,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.415: H., Smith, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.416: J., Staden, R., and Young, I. 

Phrase: "J.,"

Phrase: "Staden,"

Phrase: "R.,"

Phrase: "and"

Phrase: "Young, I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.417: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.418: (1981) Nature 290, 457465[CrossRef][Medline] [OrderarticleviaInfotrieve] Ballinger, S. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Nature 290,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "457465"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ballinger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.419: W., Shoffner, J. 

Phrase: "W., Shoffner,"

Phrase: "J."
Processing 00000000.tx.420: M., Gebhart, S., Koontz, D. 

Phrase: "M."

Phrase: ","

Phrase: "Gebhart,"

Phrase: "S."

Phrase: ","

Phrase: "Koontz,"

Phrase: "D."
Processing 00000000.tx.421: A., and Wallace, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "D."
Processing 00000000.tx.422: C. 

Phrase: "C."
Processing 00000000.tx.423: (1994) Nat. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.424: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.425: 7, 458459[Medline] [OrderarticleviaInfotrieve] Kadowaki, T., Kadowaki, H., Mori, Y., Tobe, K., Sakuta, R., Suzuki, Y., Tanabe, Y., Sakura, H., Awata, T., Goto, Y., Hayakawa, T., Matsuoka, K., Kawamori, R., Kamada, T., Horai, S., Nonaka, I., Hagura, R., Akanuma, Y., and Yazaki, Y. 

Phrase: "7,"

Phrase: "458459"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kadowaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kadowaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mori,"

Phrase: "Y.,"

Phrase: "Tobe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sakuta,"

Phrase: "R.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "Y.,"

Phrase: "Tanabe,"

Phrase: "Y.,"

Phrase: "Sakura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Awata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Goto,"

Phrase: "Y.,"

Phrase: "Hayakawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsuoka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kawamori,"

Phrase: "R.,"

Phrase: "Kamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Horai,"

Phrase: "S."

Phrase: ","

Phrase: "Nonaka,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hagura,"

Phrase: "R.,"

Phrase: "Akanuma,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Yazaki,"

Phrase: "Y."
Processing 00000000.tx.426: (1994) N. 

Phrase: "(1994"

Phrase: ")"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.427: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.428: J. 

Phrase: "J."
Processing 00000000.tx.429: Med. 

Phrase: "Med."
Processing 00000000.tx.430: 330, 962968[Abstract/Free FullText] Ballinger, S. 

Phrase: "330,"

Phrase: "962968"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ballinger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.431: W., Shoffner, J. 

Phrase: "W., Shoffner,"

Phrase: "J."
Processing 00000000.tx.432: M., Hedaya, E. 

Phrase: "M."

Phrase: ","

Phrase: "Hedaya,"

Phrase: "E."
Processing 00000000.tx.433: V., Trounce, I., Polak, M. 

Phrase: "V.,"

Phrase: "Trounce"

Phrase: ","

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Polak,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.434: A., Koontz, D. 

Phrase: "A.,"

Phrase: "Koontz,"

Phrase: "D."
Processing 00000000.tx.435: A., and Wallace, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "D."
Processing 00000000.tx.436: C. 

Phrase: "C."
Processing 00000000.tx.437: (1992) Nat. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.438: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.439: 1, 1115[Medline] [OrderarticleviaInfotrieve] Kelley, D. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "1115"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kelley,"

Phrase: "D."
Processing 00000000.tx.440: E., and Goodpaster, B. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Goodpaster,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.441: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.442: (2001) Diabetes Care 24, 933941[Abstract/Free FullText] Simoneau, J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Diabetes Care 24,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: "933941"

Phrase: "[Abstract/Free FullText"

Phrase: "] Simoneau,"

Phrase: "J."
Processing 00000000.tx.443: A., Colberg, S. 

Phrase: "A.,"

Phrase: "Colberg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.444: R., Thaete, F. 

Phrase: "R.,"

Phrase: "Thaete,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.445: L., and Kelley, D. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Kelley,"

Phrase: "D."
Processing 00000000.tx.446: E. 

Phrase: "E."
Processing 00000000.tx.447: (1995) FASEB J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.448: 9, 273278[Abstract/Free FullText] Simoneau, J. 

Phrase: "9,"

Phrase: "273278"

Phrase: "[Abstract/Free FullText"

Phrase: "] Simoneau,"

Phrase: "J."
Processing 00000000.tx.449: A., and Kelley, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Kelley,"

Phrase: "D."
Processing 00000000.tx.450: E. 

Phrase: "E."
Processing 00000000.tx.451: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.452: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.453: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.454: 83, 166171[Abstract/Free FullText] Petersen, K. 

Phrase: "83,"

Phrase: "166171"

Phrase: "[Abstract/Free FullText"

Phrase: "] Petersen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.455: F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Befroy,"

Phrase: "D.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "Dufour,"

Phrase: "S."

Phrase: ","

Phrase: "Dziura,"

Phrase: "J.,"

Phrase: "Ariyan,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Rothman,"

Phrase: "D."
Processing 00000000.tx.456: L., DiPietro, L., Cline, G. 

Phrase: "L., DiPietro,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cline,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.457: W., and Shulman, G. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Shulman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.458: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.459: (2003) Science 300, 11401142[Abstract/Free FullText] Serradas, P., Giroix, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 300,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "11401142"

Phrase: "[Abstract/Free FullText"

Phrase: "] Serradas,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Giroix,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.460: H., Saulnier, C., Gangnerau, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saulnier,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Gangnerau,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.461: N., Borg, L. 

Phrase: "N., Borg,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.462: A., Welsh, M., Portha, B., and Welsh, N. 

Phrase: "A.,"

Phrase: "Welsh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "Portha,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Welsh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.463: (1995) Endocrinology 136, 56235631[Abstract] Antonetti, D. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Endocrinology 136,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "56235631"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Antonetti,"

Phrase: "D."
Processing 00000000.tx.464: A., Reynet, C., and Kahn, C. 

Phrase: "A.,"

Phrase: "Reynet,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Kahn,"

Phrase: "C."
Processing 00000000.tx.465: R. 

Phrase: "R."
Processing 00000000.tx.466: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.467: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.468: Invest. 

Phrase: "Invest."
Processing 00000000.tx.469: 95, 13831388[Medline] [OrderarticleviaInfotrieve] Lee, H. 

Phrase: "95,"

Phrase: "13831388"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.470: K., Song, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.471: H., Shin, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230444:Shin [Body Location or Region]

Phrase: "C."
Processing 00000000.tx.472: S., Park, D. 

Phrase: "S."

Phrase: ","

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "D."
Processing 00000000.tx.473: J., Park, K. 

Phrase: "J.,"

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.474: S., Lee, K. 

Phrase: "S."

Phrase: ","

Phrase: "Lee,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.475: U., and Koh, C. 

Phrase: "U.,"

Phrase: "and"

Phrase: "Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "C."
Processing 00000000.tx.476: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.477: (1998) Diabetes Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Diabetes Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.478: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.479: Pract. 

Phrase: "Pract."
Processing 00000000.tx.480: 42, 161167[CrossRef][Medline] [OrderarticleviaInfotrieve] Zylber, E., Vesco, C., and Penman, S. 

Phrase: "42,"

Phrase: "161167"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zylber,"

Phrase: "E.,"

Phrase: "Vesco,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Penman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.481: (1969) J. 

Phrase: "(1969"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.482: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.483: Biol. 

Phrase: "Biol."
Processing 00000000.tx.484: 44, 195204[Medline] [OrderarticleviaInfotrieve] Desjardins, P., Frost, E., and Morais, R. 

Phrase: "44,"

Phrase: "195204"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Desjardins,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Frost,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0452566:frosty [Food]

Phrase: "E.,"

Phrase: "and"

Phrase: "Morais,"

Phrase: "R."
Processing 00000000.tx.485: (1985) Mol. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.486: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.487: Biol. 

Phrase: "Biol."
Processing 00000000.tx.488: 5, 11631169[Medline] [OrderarticleviaInfotrieve] Hayakawa, T., Noda, M., Yasuda, K., Yorifuji, H., Taniguchi, S., Miwa, I., Sakura, H., Terauchi, Y., Hayashi, J., Sharp, G. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "11631169"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hayakawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Noda,"

Phrase: "M."

Phrase: ","

Phrase: "Yasuda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yorifuji,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Taniguchi,"

Phrase: "S."

Phrase: ","

Phrase: "Miwa,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sakura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Terauchi,"

Phrase: "Y.,"

Phrase: "Hayashi,"

Phrase: "J.,"

Phrase: "Sharp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1444775:Sharp [Finding]
  1000   C1539835:SHARP [Gene or Genome]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.489: W., Kanazawa, Y., Akanuma, Y., Yazaki, Y., and Kadowaki, T. 

Phrase: "W., Kanazawa,"

Phrase: "Y.,"

Phrase: "Akanuma,"

Phrase: "Y.,"

Phrase: "Yazaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Kadowaki,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.490: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.491: Biol. 

Phrase: "Biol."
Processing 00000000.tx.492: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.493: 273, 2030020307[Abstract/Free FullText] King, M. 

Phrase: "273,"

Phrase: "2030020307"

Phrase: "[Abstract/Free FullText"

Phrase: "] King,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.494: P., and Attardi, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Attardi,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.495: (1989) Science 246, 500503[Medline] [OrderarticleviaInfotrieve] Biswas, G., Adebanjo, O. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Science 246,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "500503"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Biswas,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Adebanjo,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.496: A., Freedman, B. 

Phrase: "A.,"

Phrase: "Freedman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.497: D., Anandatheerthavarada, H. 

Phrase: "D.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "Anandatheerthavarada,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.498: K., Vijayasarathy, C., Zaidi, M., Kotlikoff, M., and Avadhani, N. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vijayasarathy,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Zaidi,"

Phrase: "M."

Phrase: ","

Phrase: "Kotlikoff,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Avadhani,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.499: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.500: (1999) EMBO J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.501: 18, 522533[Abstract/Free FullText] Amuthan, G., Biswas, G., Ananadatheerthavarada, H. 

Phrase: "18,"

Phrase: "522533"

Phrase: "[Abstract/Free FullText"

Phrase: "] Amuthan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Biswas,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ananadatheerthavarada,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.502: K., Vijayasarathy, C., Shephard, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vijayasarathy,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Shephard,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.503: M., and Avadhani, N. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Avadhani,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.504: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.505: (2002) Oncogene 21, 78397849[CrossRef][Medline] [OrderarticleviaInfotrieve] Amuthan, G., Biswas, G., Zhang, S. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Oncogene 21,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "78397849"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Amuthan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Biswas,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.506: Y., Klein-Szanto, A., Vijayasarathy, C., and Avadhani, N. 

Phrase: "Y.,"

Phrase: "Klein-Szanto,"

Phrase: "A.,"

Phrase: "Vijayasarathy,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Avadhani,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.507: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.508: (2001) EMBO J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.509: 20, 19101920[Abstract/Free FullText] Biswas, G., Anandatheerthavarada, H. 

Phrase: "20,"

Phrase: "19101920"

Phrase: "[Abstract/Free FullText"

Phrase: "] Biswas,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Anandatheerthavarada,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.510: K., Zaidi, M., and Avadhani, N. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zaidi,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Avadhani,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.511: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.512: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.513: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.514: 161, 507519[Abstract/Free FullText] Kanai, F., Nishioka, Y., Hayashi, H., Kamohara, S., Todaka, M., and Ebina, Y. 

Phrase: "161,"

Phrase: "507519"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kanai,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nishioka,"

Phrase: "Y.,"

Phrase: "Hayashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kamohara,"

Phrase: "S."

Phrase: ","

Phrase: "Todaka,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ebina,"

Phrase: "Y."
Processing 00000000.tx.515: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.516: Biol. 

Phrase: "Biol."
Processing 00000000.tx.517: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.518: 268, 1452314526[Abstract/Free FullText] Herzberg, N. 

Phrase: "268,"

Phrase: "1452314526"

Phrase: "[Abstract/Free FullText"

Phrase: "] Herzberg,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.519: H., Zwart, R., Wolterman, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zwart,"

Phrase: "R.,"

Phrase: "Wolterman,"

Phrase: "R."
Processing 00000000.tx.520: A., Ruiter, J. 

Phrase: "A.,"

Phrase: "Ruiter,"

Phrase: "J."
Processing 00000000.tx.521: P., Wanders, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wanders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233569:wander [Finding]

Phrase: ","

Phrase: "R."
Processing 00000000.tx.522: J., Bolhuis, P. 

Phrase: "J.,"

Phrase: "Bolhuis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.523: A., and van den Bogert, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "van den Bogert,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "C."
Processing 00000000.tx.524: (1993) Biochim. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.525: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.526: Acta 1181, 6367[Medline] [OrderarticleviaInfotrieve] Wang, Q., Khayat, Z., Kishi, K., Ebina, Y., and Klip, A. 

Phrase: "Acta 1181,"

Phrase: "6367"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wang,"

Phrase: "Q.,"

Phrase: "Khayat,"

Phrase: "Z.,"

Phrase: "Kishi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ebina,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Klip,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426024:KLIP [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.527: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.528: 427, 193197[CrossRef][Medline] [OrderarticleviaInfotrieve] Ueyama, A., Yaworsky, K. 

Phrase: "427,"

Phrase: "193197"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ueyama,"

Phrase: "A.,"

Phrase: "Yaworsky,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.529: L., Wang, Q., Ebina, Y., and Klip, A. 

Phrase: "L., Wang,"

Phrase: "Q.,"

Phrase: "Ebina,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Klip,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426024:KLIP [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.530: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.531: J. 

Phrase: "J."
Processing 00000000.tx.532: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.533: 277, E572E578[Medline] [OrderarticleviaInfotrieve] Li, D., Randhawa, V. 

Phrase: "277,"

Phrase: "E572E578"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "D.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "Randhawa,"

Phrase: "V."
Processing 00000000.tx.534: K., Patel, N., Hayashi, M., and Klip, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Patel,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hayashi,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Klip,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426024:KLIP [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.535: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.536: Biol. 

Phrase: "Biol."
Processing 00000000.tx.537: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.538: 276, 2288322891[Abstract/Free FullText] Wang, Q., Somwar, R., Bilan, P. 

Phrase: "276,"

Phrase: "2288322891"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang,"

Phrase: "Q.,"

Phrase: "Somwar,"

Phrase: "R.,"

Phrase: "Bilan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.539: J., Liu, Z., Jin, J., Woodgett, J. 

Phrase: "J.,"

Phrase: "Liu,"

Phrase: "Z.,"

Phrase: "Jin,"

Phrase: "J.,"

Phrase: "Woodgett,"

Phrase: "J."
Processing 00000000.tx.540: R., and Klip, A. 

Phrase: "R.,"

Phrase: "and"

Phrase: "Klip,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426024:KLIP [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.541: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.542: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.543: Biol. 

Phrase: "Biol."
Processing 00000000.tx.544: 19, 40084018[Abstract/Free FullText] Khayat, Z. 

Phrase: "19,"

Phrase: "40084018"

Phrase: "[Abstract/Free FullText"

Phrase: "] Khayat,"

Phrase: "Z."
Processing 00000000.tx.545: A., Tong, P., Yaworsky, K., Bloch, R. 

Phrase: "A.,"

Phrase: "Tong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183964:Tong [Medical Device]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yaworsky,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bloch,"

Phrase: "R."
Processing 00000000.tx.546: J., and Klip, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Klip,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426024:KLIP [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.547: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.548: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.549: 113, 279290[Abstract/Free FullText] Tong, P., Khayat, Z. 

Phrase: "113,"

Phrase: "279290"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183964:Tong [Medical Device]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Khayat,"

Phrase: "Z."
Processing 00000000.tx.550: A., Huang, C., Patel, N., Ueyama, A., and Klip, A. 

Phrase: "A.,"

Phrase: "Huang,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Patel,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ueyama,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Klip,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426024:KLIP [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.551: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.552: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.553: Invest. 

Phrase: "Invest."
Processing 00000000.tx.554: 108, 371381[Abstract/Free FullText] Chen, L. 

Phrase: "108,"

Phrase: "371381"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.555: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.556: (1989) Methods Cell Biol. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Methods Cell Biol."
Processing 00000000.tx.557: 29, 103123[Medline] [OrderarticleviaInfotrieve] Han, J. 

Phrase: "29,"

Phrase: "103123"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "J."
Processing 00000000.tx.558: C., Park, S. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.559: Y., Hah, B. 

Phrase: "Y.,"

Phrase: "Hah,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.560: G., Choi, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Choi,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.561: H., Kim, Y. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "Y."
Processing 00000000.tx.562: K., Kwon, T. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kwon,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.563: H., Kim, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "E."
Processing 00000000.tx.564: K., Lachaal, M., Jung, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lachaal,"

Phrase: "M."

Phrase: ","

Phrase: "Jung,"

Phrase: "C."
Processing 00000000.tx.565: Y., and Lee, W. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "W."
Processing 00000000.tx.566: (2003) Arch Biochem. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Arch Biochem."
Processing 00000000.tx.567: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.568: 413, 213220[CrossRef][Medline] [OrderarticleviaInfotrieve] Sweeney, G., Somwar, R., Ramlal, T., Volchuk, A., Ueyama, A., and Klip, A. 

Phrase: "413,"

Phrase: "213220"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sweeney,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0270811:Sweeney [Disease or Syndrome]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Somwar,"

Phrase: "R.,"

Phrase: "Ramlal,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Volchuk,"

Phrase: "A.,"

Phrase: "Ueyama,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Klip,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426024:KLIP [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.569: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.570: Biol. 

Phrase: "Biol."
Processing 00000000.tx.571: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.572: 274, 1007110078[Abstract/Free FullText] Laemmli, U. 

Phrase: "274,"

Phrase: "1007110078"

Phrase: "[Abstract/Free FullText"

Phrase: "] Laemmli,"

Phrase: "U."
Processing 00000000.tx.573: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.574: (1970) Nature 227, 680685[Medline] [OrderarticleviaInfotrieve] Huang, C., Somwar, R., Patel, N., Niu, W., Torok, D., and Klip, A. 

Phrase: "(1970"

Phrase: ")"

Phrase: "Nature 227,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "680685"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Huang,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Somwar,"

Phrase: "R.,"

Phrase: "Patel,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Niu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028219:NIU [Geographic Area]

Phrase: "W.,"

Phrase: "Torok,"

Phrase: "D.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "and"

Phrase: "Klip,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426024:KLIP [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.575: (2002) Diabetes 51, 20902098[Abstract/Free FullText] Kennedy, E. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Diabetes 51,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "20902098"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kennedy,"

Phrase: "E."
Processing 00000000.tx.576: D., Maechler, P., and Wollheim, C. 

Phrase: "D.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "Maechler,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.577: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.578: (1998) Diabetes 47, 374380[Abstract] Park, K. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Diabetes 47,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "374380"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.579: S., Nam, K. 

Phrase: "S."

Phrase: ","

Phrase: "Nam,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027366:NAM [Geographic Area]
  1000   C1850625:NAM [Disease or Syndrome]
  1000   C2826269:NAM [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.580: J., Kim, J. 

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "J."
Processing 00000000.tx.581: W., Lee, Y. 

Phrase: "W., Lee,"

Phrase: "Y."
Processing 00000000.tx.582: B., Han, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "C."
Processing 00000000.tx.583: Y., Jeong, J. 

Phrase: "Y.,"

Phrase: "Jeong,"

Phrase: "J."
Processing 00000000.tx.584: K., Lee, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.585: K., and Pak, Y. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Pak,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030211:PAK [Geographic Area]

Phrase: "Y."
Processing 00000000.tx.586: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.587: (2001) Am. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.588: J. 

Phrase: "J."
Processing 00000000.tx.589: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.590: 280, E1007E1014 Holman, G. 

Phrase: "280,"

Phrase: "E1007E1014 Holman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.591: D., and Sandoval, I. 

Phrase: "D.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "and"

Phrase: "Sandoval,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.592: V. 

Phrase: "V."
Processing 00000000.tx.593: (2001) Trends Cell Biol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol."
Processing 00000000.tx.594: 11, 173179[CrossRef][Medline] [OrderarticleviaInfotrieve] Khan, A. 

Phrase: "11,"

Phrase: "173179"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Khan,"

Phrase: "A."
Processing 00000000.tx.595: H., and Pessin, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Pessin,"

Phrase: "J."
Processing 00000000.tx.596: E. 

Phrase: "E."
Processing 00000000.tx.597: (2002) Diabetologia 45, 14751483[CrossRef][Medline] [OrderarticleviaInfotrieve] Whitehead, J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Diabetologia 45,"

Phrase: "14751483"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Whitehead,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302302:Whitehead [Pathologic Function]

Phrase: "J."
Processing 00000000.tx.598: P., Clark, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Clark,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.599: F., Urso, B., and James, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Urso,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0724157:Urso [Organic Chemical,Pharmacologic Substance]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "James,"

Phrase: "D."
Processing 00000000.tx.600: E. 

Phrase: "E."
Processing 00000000.tx.601: (2000) Curr. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.602: Opin. 

Phrase: "Opin."
Processing 00000000.tx.603: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.604: 12, 222228[CrossRef][Medline] [OrderarticleviaInfotrieve] Simoneau, J. 

Phrase: "12,"

Phrase: "222228"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Simoneau,"

Phrase: "J."
Processing 00000000.tx.605: A., Veerkamp, J. 

Phrase: "A.,"

Phrase: "Veerkamp,"

Phrase: "J."
Processing 00000000.tx.606: H., Turcotte, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Turcotte,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.607: P., and Kelley, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Kelley,"

Phrase: "D."
Processing 00000000.tx.608: E. 

Phrase: "E."
Processing 00000000.tx.609: (1999) FASEB J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.610: 13, 20512060[Abstract/Free FullText] Kruszynska, Y. 

Phrase: "13,"

Phrase: "20512060"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kruszynska,"

Phrase: "Y."
Processing 00000000.tx.611: T., Mulford, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mulford,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.612: I., Baloga, J., Yu, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Baloga,"

Phrase: "J.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "J."
Processing 00000000.tx.613: G., and Olefsky, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Olefsky,"

Phrase: "J."
Processing 00000000.tx.614: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.615: (1998) Diabetes 47, 11071113[Abstract] Kelley, D. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Diabetes 47,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "11071113"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kelley,"

Phrase: "D."
Processing 00000000.tx.616: E., He, J., Menshikova, E. 

Phrase: "E.,"

Phrase: "He,"

Phrase: "J.,"

Phrase: "Menshikova,"

Phrase: "E."
Processing 00000000.tx.617: V., and Ritov, V. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Ritov,"

Phrase: "V."
Processing 00000000.tx.618: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.619: (2002) Diabetes 51, 29442950[Abstract/Free FullText] Seidel-Rogol, B. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Diabetes 51,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "29442950"

Phrase: "[Abstract/Free FullText"

Phrase: "] Seidel-Rogol,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.620: L., and Shadel, G. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Shadel,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.621: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.622: (2002) Nucleic Acids Res. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.623: 30, 19291934[Abstract/Free FullText] Stenbit, A. 

Phrase: "30,"

Phrase: "19291934"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stenbit,"

Phrase: "A."
Processing 00000000.tx.624: E., Tsao, T. 

Phrase: "E.,"

Phrase: "Tsao,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.625: S., Li, J., Burcelin, R., Geenen, D. 

Phrase: "S."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "Burcelin,"

Phrase: "R.,"

Phrase: "Geenen,"

Phrase: "D."
Processing 00000000.tx.626: L., Factor, S. 

Phrase: "L., Factor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.627: M., Houseknecht, K., Katz, E. 

Phrase: "M."

Phrase: ","

Phrase: "Houseknecht,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Katz,"

Phrase: "E."
Processing 00000000.tx.628: B., and Charron, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Charron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.629: J. 

Phrase: "J."
Processing 00000000.tx.630: (1997) Nat. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.631: Med. 

Phrase: "Med."
Processing 00000000.tx.632: 3, 10961101[CrossRef][Medline] [OrderarticleviaInfotrieve] Hansen, P. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "10961101"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hansen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.633: A., Gulve, E. 

Phrase: "A.,"

Phrase: "Gulve,"

Phrase: "E."
Processing 00000000.tx.634: A., Marshall, B. 

Phrase: "A.,"

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.635: A., Gao, J., Pessin, J. 

Phrase: "A.,"

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Pessin,"

Phrase: "J."
Processing 00000000.tx.636: E., Holloszy, J. 

Phrase: "E.,"

Phrase: "Holloszy,"

Phrase: "J."
Processing 00000000.tx.637: O., and Mueckler, M. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Mueckler,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.638: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.639: Biol. 

Phrase: "Biol."
Processing 00000000.tx.640: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.641: 270, 16791684[Free FullText] Kanzaki, M., and Pessin, J. 

Phrase: "270,"

Phrase: "16791684"

Phrase: "[Free FullText"

Phrase: "] Kanzaki,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Pessin,"

Phrase: "J."
Processing 00000000.tx.642: E. 

Phrase: "E."
Processing 00000000.tx.643: (2003) Curr. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.644: Biol. 

Phrase: "Biol."
Processing 00000000.tx.645: 13, R574576[CrossRef][Medline] [OrderarticleviaInfotrieve] Saltiel, A. 

Phrase: "13,"

Phrase: "R574576"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Saltiel,"

Phrase: "A."
Processing 00000000.tx.646: R., and Pessin, J. 

Phrase: "R.,"

Phrase: "and"

Phrase: "Pessin,"

Phrase: "J."
Processing 00000000.tx.647: E. 

Phrase: "E."
Processing 00000000.tx.648: (2002) Trends Cell Biol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol."
Processing 00000000.tx.649: 12, 6571[CrossRef][Medline] [OrderarticleviaInfotrieve] Bjornholm, M., Kawano, Y., Lehtihet, M., and Zierath, J. 

Phrase: "12,"

Phrase: "6571"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bjornholm,"

Phrase: "M."

Phrase: ","

Phrase: "Kawano,"

Phrase: "Y.,"

Phrase: "Lehtihet,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Zierath,"

Phrase: "J."
Processing 00000000.tx.650: R. 

Phrase: "R."
Processing 00000000.tx.651: (1997) Diabetes 46, 524527[Abstract] Krook, A., Roth, R. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Diabetes 46,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "524527"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Krook,"

Phrase: "A.,"

Phrase: "Roth,"

Phrase: "R."
Processing 00000000.tx.652: A., Jiang, X. 

Phrase: "A.,"

Phrase: "Jiang,"

Phrase: "X."
Processing 00000000.tx.653: J., Zierath, J. 

Phrase: "J.,"

Phrase: "Zierath,"

Phrase: "J."
Processing 00000000.tx.654: R., and Wallberg-Henriksson, H. 

Phrase: "R.,"

Phrase: "and"

Phrase: "Wallberg-Henriksson,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.655: (1998) Diabetes 47, 12811286[Abstract] Saad, M. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Diabetes 47,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "12811286"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Saad,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.656: J., Folli, F., Kahn, J. 

Phrase: "J.,"

Phrase: "Folli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kahn,"

Phrase: "J."
Processing 00000000.tx.657: A., and Kahn, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Kahn,"

Phrase: "C."
Processing 00000000.tx.658: R. 

Phrase: "R."
Processing 00000000.tx.659: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.660: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.661: Invest. 

Phrase: "Invest."
Processing 00000000.tx.662: 92, 20652072[Medline] [OrderarticleviaInfotrieve] Anai, M., Funaki, M., Ogihara, T., Terasaki, J., Inukai, K., Katagiri, H., Fukushima, Y., Yazaki, Y., Kikuchi, M., Oka, Y., and Asano, T. 

Phrase: "92,"

Phrase: "20652072"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Anai,"

Phrase: "M."

Phrase: ","

Phrase: "Funaki,"

Phrase: "M."

Phrase: ","

Phrase: "Ogihara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Terasaki,"

Phrase: "J.,"

Phrase: "Inukai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Katagiri,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fukushima,"

Phrase: "Y.,"

Phrase: "Yazaki,"

Phrase: "Y.,"

Phrase: "Kikuchi,"

Phrase: "M."

Phrase: ","

Phrase: "Oka,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069389:OKA [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Asano,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.663: (1998) Diabetes 47, 1323[Abstract] Kerouz, N. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Diabetes 47,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1323"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kerouz,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.664: J., Horsch, D., Pons, S., and Kahn, C. 

Phrase: "J.,"

Phrase: "Horsch,"

Phrase: "D.,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "Pons,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0032639:Pons [Body Part, Organ, or Organ Component]
  1000   C1280999:Pons [Body Part, Organ, or Organ Component]
   966 E C1418754:PON [Gene or Genome]
   966 E C1709588:PON [Mammal]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kahn,"

Phrase: "C."
Processing 00000000.tx.665: R. 

Phrase: "R."
Processing 00000000.tx.666: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.667: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.668: Invest. 

Phrase: "Invest."
Processing 00000000.tx.669: 100, 31643172[Abstract/Free FullText] Yamauchi, T., Tobe, K., Tamemoto, H., Ueki, K., Kaburagi, Y., Yamamoto-Honda, R., Takahashi, Y., Yoshizawa, F., Aizawa, S., Akanuma, Y., Sonenberg, N., Yazaki, Y., and Kadowaki, T. 

Phrase: "100,"

Phrase: "31643172"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yamauchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tobe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tamemoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ueki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kaburagi,"

Phrase: "Y.,"

Phrase: "Yamamoto-Honda,"

Phrase: "R.,"

Phrase: "Takahashi,"

Phrase: "Y.,"

Phrase: "Yoshizawa,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Aizawa,"

Phrase: "S."

Phrase: ","

Phrase: "Akanuma,"

Phrase: "Y.,"

Phrase: "Sonenberg,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Yazaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Kadowaki,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.670: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.671: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.672: Biol. 

Phrase: "Biol."
Processing 00000000.tx.673: 16, 30743084[Abstract] Higaki, Y., Wojtaszewski, J. 

Phrase: "16,"

Phrase: "30743084"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Higaki,"

Phrase: "Y.,"

Phrase: "Wojtaszewski,"

Phrase: "J."
Processing 00000000.tx.674: F., Hirshman, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hirshman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.675: F., Withers, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Withers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230107:Withers [Body Part, Organ, or Organ Component]

Phrase: ","

Phrase: "D."
Processing 00000000.tx.676: J., Towery, H., White, M. 

Phrase: "J.,"

Phrase: "Towery,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.677: F., and Goodyear, L. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Goodyear,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.678: J. 

Phrase: "J."
Processing 00000000.tx.679: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.680: Biol. 

Phrase: "Biol."
Processing 00000000.tx.681: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.682: 274, 2079120795[Abstract/Free FullText] Zick, Y. 

Phrase: "274,"

Phrase: "2079120795"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zick,"

Phrase: "Y."
Processing 00000000.tx.683: (2001) Trends Cell Biol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol."
Processing 00000000.tx.684: 11, 437441[CrossRef][Medline] [OrderarticleviaInfotrieve] White, M. 

Phrase: "11,"

Phrase: "437441"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.685: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.686: (2003) Science 302, 17101711[Abstract/Free FullText] Li, Y., Soos, T. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 302,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "17101711"

Phrase: "[Abstract/Free FullText"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y.,"

Phrase: "Soos,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.687: J., Li, X., Wu, J., Degennaro, M., Sun, X., Littman, D. 

Phrase: "J.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "J.,"

Phrase: "Degennaro,"

Phrase: "M."

Phrase: ","

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X.,"

Phrase: "Littman,"

Phrase: "D."
Processing 00000000.tx.688: R., Birnbaum, M. 

Phrase: "R.,"

Phrase: "Birnbaum,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.689: J., and Polakiewicz, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Polakiewicz,"

Phrase: "R."
Processing 00000000.tx.690: D. 

Phrase: "D."
Processing 00000000.tx.691: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.692: Biol. 

Phrase: "Biol."
Processing 00000000.tx.693: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.694: 279, 4530445307[Abstract/Free FullText]

Phrase: "279,"

Phrase: "4530445307"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

